{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ef04d696",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing PDFs:   0%|          | 0/3 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "üîç Processing [1] #1 - Ahn 2020.pdf\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing PDFs:   0%|          | 0/3 [00:11<?, ?it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Status info: Run(id='run_RelPqwpVYIoRN5Y5G8bgBPlw', assistant_id='asst_lv3278Ccd2N2HL5s1WnKGP7W', cancelled_at=None, completed_at=None, created_at=1751503380, expires_at=None, failed_at=1751503387, incomplete_details=None, instructions='I am conducting a Methods Audit of Mendelian Randomization (MR) studies using a study characteristics form and a structured scoring rubric. I will upload the MR study as a PDF file.\\n\\nPlease do the following:\\n\\n**1\\\\. Use the attached study characteristics form to extract the relevant data from the MR study.**\\n\\n**2\\\\. Use the attached rubric (Parts A and B) to score the MR study.**\\n\\n- Score each item as 0, 1, or N/A based on the rubric\\'s detailed evaluation criteria.\\n\\n**3\\\\. Output Format (JSON)**\\n\\nReturn only a single structured JSON object with the following three components.\\nDo not include any explanations, notes, or additional text.\\n\\n1. **characteristics  \\n    Contains extracted responses for each item in the Study Characteristics Form (Q1‚ÄìQ20).**\\n2. **scoring  \\n    Includes scores for each rubric item in Part A (A1‚ÄìA12) and Part B (B1‚ÄìB12), using 0, 1, or \"N/A\".**\\n3. **evidence  \\n    For each item in A1‚ÄìA12 and B1‚ÄìB12, include:**\\n    - **score: the assigned value (0, 1, or \"N/A\")**\\n    - **quote: verbatim excerpt from the paper**\\n    - **section: the section where the quote was found (e.g., \"Methods\", \"Results\")**\\n\\n**Use the PDF file name as the value for study_id.**\\n\\n**Example Output Format**\\n\\n```json\\n{\\n  \"study_id\": \"Chen2022.pdf\",\\n  \"characteristics\": {\\n    \"Q1\": \"...\",\\n    \"Q2\": \"...\",\\n    \"Q3\": \"...\",\\n    \"...\": \"...\",\\n    \"Q20\": \"...\"\\n  },\\n  \"scoring\": {\\n    \"A\": {\\n      \"A1\": 1,\\n      \"A2\": 0,\\n      \"...\": \"N/A\"\\n    },\\n    \"B\": {\\n      \"B1\": 1,\\n      \"B2\": 0,\\n      \"...\": \"N/A\"\\n    }\\n  },\\n  \"evidence\": {\\n    \"A\": {\\n      \"A1\": {\\n        \"score\": 1,\\n        \"quote\": \"...verbatim text from paper...\",\\n        \"section\": \"Methods ‚Äì Instrument Selection\"\\n      },\\n      \"A2\": {\\n        \"score\": 0,\\n        \"quote\": \"N/A\",\\n        \"section\": \"N/A\"\\n      }\\n    },\\n    \"B\": {\\n      \"B1\": {\\n        \"score\": 1,\\n        \"quote\": \"...\",\\n        \"section\": \"Results ‚Äì Sample Characteristics\"\\n      }\\n    }\\n  }\\n}\\n```\\n\\n**Notes:**\\n\\n- Follow the rubric‚Äôs critical item and quality threshold rules if applicable.\\n- If any item is unclear or cannot be determined from the study, mark it as N/A and briefly explain why.\\n\\n# Study Characteristics Form\\n\\n| **Label** | **Field** | **Question** |\\n| --- | --- | --- |\\n| Q1  | Study ID | What is the study‚Äôs citation shorthand (first author and publication year, e.g. Storm 2023)? |\\n| Q2  | Study Title | What is the full title of the article? |\\n| Q3  | Journal | What is the full name of the journal in which the article was published? |\\n| Q4  | Publication Year | In what year was the article published? |\\n| Q5  | Study Design / MR Type | What type(s) of MR design(s) were used? (e.g. One-sample MR, Two-sample MR, Multivariable MR, Bidirectional MR, or combinations) |\\n| Q6  | Instrumental Variable(s) | What types of genetic instruments were used (e.g. GWAS SNPs, cis-variants, PRS)? If SNPs were LD-clumped, what were the clumping parameters (e.g. r¬≤ threshold, physical distance window)? |\\n| Q7  | Number of SNPs per Exposure | How many SNPs were used for each exposure? Report counts separately for each exposure and ancestry group.<br><br>Example: BMI: 62 SNPs (EAS), 298 SNPs (EUR); CRP: 6 SNPs (EAS), 183 SNPs (EUR); HDL-C: 50 SNPs (EAS), 247 SNPs (EUR); BS: 15 SNPs (EAS), 93 SNPs (EUR); TGs: 36 SNPs (EAS), 204 SNPs (EUR); SBP: 22 SNPs (EAS), 158 SNPs (EUR) |\\n| Q8  | Exposure(s) | What traits, biomarkers, or risk factors were analyzed as exposures? |\\n| Q9  | Outcome(s) | What traits, diseases, or phenotypes were analyzed as outcomes? |\\n| Q10 | Number of Exposures Assessed | How many distinct exposures were included? |\\n| Q11 | Number of Outcomes Assessed | How many distinct outcomes were assessed? |\\n| Q12 | GWAS Source for Exposure(s) | What GWAS datasets or consortia provided SNP‚Äìexposure associations? List all.<br><br>Example: ALT/AST: UK Biobank (Neale Lab); NAFLD liability: Million Veteran Program; liver MRI: UK Biobank subset; East Asian: Biobank Japan |\\n| Q13 | GWAS Source for Outcome(s) | What GWAS datasets or consortia provided SNP‚Äìoutcome associations? List all.<br><br>Example: CAD: CARDIoGRAM; stroke: MEGASTROKE; atrial fibrillation: published GWAS; heart failure: HERMES consortium; T2D: DIAMANTE consortium; glycaemic traits: MAGIC; East Asian: Biobank Japan, AGEN consortium |\\n| Q14 | Sample Size for Exposure(s) | What was the total sample size for each exposure dataset, including cases and controls if applicable? |\\n| Q15 | Sample Size for Outcome(s) | What was the total sample size for each outcome dataset, including cases and controls if applicable? |\\n| Q16 | Ancestries Represented in Exposure GWAS | What ancestry groups were included in the exposure GWAS (e.g. European, East Asian)? |\\n| Q17 | Ancestries Represented in Outcome GWAS | What ancestry groups were included in the outcome GWAS? |\\n| Q18 | Separate MR Analyses by Ancestry | Did the study conduct ancestry-stratified MR analyses? (Yes/No) |\\n| Q19 | Geographic Region(s) Represented | What geographic regions or countries were the study populations drawn from |\\n| Q20 | Software Used | What statistical software, packages, or MR tools were used (e.g. R, Stata, TwoSampleMR, MR-Base, GSMR, LDSC)? |\\n\\n# Scoring Rubric\\n\\n### Part A: Core MR Methodology\\n\\n**Scoring Instructions**:\\n\\n- **0 = Not Addressed**: Item missing or not discussed anywhere in paper\\n- **1 = Fully Addressed**: Item explicitly addressed with required elements present\\n- **N/A**: Item clearly not applicable to study design\\n- **Specific numeric thresholds and keywords are provided below to minimize reviewer interpretation**\\n\\n<table><tbody><tr><th><p><strong>Item</strong></p></th><th><p><strong>Category</strong></p></th><th><p><strong>Question</strong></p></th><th><p><strong>Evaluation Criteria</strong></p></th></tr><tr><td><p><strong>A1</strong></p></td><td><p><strong>Data Sources</strong></p></td><td><p>Are Exposure and Outcome GWAS described with source, ancestry, and sample size?</p></td><td><p><strong>Score 1 if ALL of the following for BOTH exposure and outcome GWAS:</strong></p><ul><li>Source identification: Study name (e.g., ‚ÄúUK Biobank‚Äù), consortium (e.g., ‚ÄúGIANT‚Äù), or specific cohort clearly stated</li><li>Sample size: Total N provided as specific number (not ranges like ‚Äú~500,000‚Äù)</li><li>Ancestry composition: Population ancestry explicitly stated using standard terms or percentages</li></ul><p><strong>Score 0 if ANY element missing or vague:</strong></p><ul><li>Source described only as ‚Äúpublished GWAS‚Äù or ‚Äúlarge-scale study‚Äù</li><li>Sample size missing, unclear, or given as approximation</li><li>Ancestry not specified or described only as ‚Äúmixed‚Äù without detail</li></ul></td></tr><tr><td><p><strong>A2</strong></p></td><td><p><strong>Instrument Selection</strong></p></td><td><p>Are SNP instruments selected using genome-wide significance and LD pruning/clumping with parameters specified?</p></td><td><p><strong>Score 1 if ALL of the following criteria present:</strong></p><ul><li>Genome-wide significance: p &lt; 5√ó10‚Åª‚Å∏ threshold explicitly stated</li><li>LD pruning/clumping: Method clearly specified (pruning OR clumping)</li><li>LD parameters: r¬≤ threshold stated (e.g., r¬≤ &lt; 0.001, r¬≤ &lt; 0.01)</li><li>Distance parameter: Window size specified (e.g., 1MB, 250kb, 10,000kb)</li><li>Reference panel: LD reference panel named (e.g., ‚Äú1000 Genomes Phase 3‚Äù)</li></ul><p><strong>Score 0 if ANY of the following:</strong></p><ul><li>Different p-value threshold used (e.g., p &lt; 5√ó10‚Åª‚Å∂) without justification</li><li>LD method not specified (‚Äúindependent SNPs‚Äù without method)</li><li>Parameters missing (r¬≤ or distance threshold not provided)</li><li>Reference panel not identified</li></ul></td></tr><tr><td><p><strong>A3a</strong></p></td><td><p><strong>Instrument Strength - Reporting</strong></p></td><td><p>Is instrument strength reported using F-statistics or R¬≤?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li>F-statistics provided with values (per instrument OR mean F-statistic)</li><li>R¬≤ (variance explained) provided as percentage or proportion</li><li>Both F-statistics and R¬≤ reported</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Strength mentioned but no values provided (e.g., ‚Äústrong instruments‚Äù)</li><li>Only weak instrument bias mentioned without metrics</li><li>No mention of instrument strength</li></ul></td></tr><tr><td><p><strong>A3b</strong></p></td><td><p><strong>Instrument Strength - Adequacy</strong></p></td><td><p>If F-statistics reported, are they adequate (F ‚â• 10)?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>F ‚â• 10</li></ul><p><strong>Score 0 if:</strong></p><ul><li>F &lt; 10</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>F-statistics not reported</li></ul></td></tr><tr><td><p><strong>A4</strong></p></td><td><p><strong>MR Assumptions</strong></p></td><td><p>Are the three core IV assumptions explicitly stated and at least one empirically evaluated?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li><strong>All three assumptions named: </strong>Relevance (instrument-exposure association), Independence (no confounding), Exclusion restriction (no pleiotropy)</li><li><strong>At least one assumption empirically tested</strong> using ANY of:</li><li>Confounder association testing (PhenoScanner, manual curation)</li><li>Known confounder control testing</li><li>Pleiotropy detection methods (MR-Egger, MR-PRESSO)</li><li>Negative control analyses</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Assumptions mentioned but not all three clearly identified</li><li>No empirical evaluation of any assumption</li><li>Only theoretical discussion without testing</li></ul></td></tr><tr><td><p><strong>A5</strong></p></td><td><p><strong>Harmonization</strong></p></td><td><p>Are effect alleles harmonized and strand alignment issues addressed between datasets?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following approaches clearly described:</strong></p><ul><li><strong>Automated harmonization: </strong>Use of harmonization functions/packages (e.g., TwoSampleMR harmonise_data(), MungeSumstats)</li><li><strong>Manual harmonization: </strong>Process for aligning effect alleles described with specific steps</li><li><strong>Strand flip handling:</strong> Explicit mention of identifying and correcting strand flips</li><li><strong>Ambiguous SNP removal: </strong>A/T and G/C SNPs excluded or handled with frequency-based inference</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No mention of harmonization procedures</li><li>Only states ‚Äúdata were harmonized‚Äù without method description</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>Single-sample MR study</li></ul></td></tr><tr><td><p><strong>A6</strong></p></td><td><p><strong>Palindromic SNPs</strong></p></td><td><p>Are palindromic (A/T, G/C) SNPs handled appropriately?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li><strong>Exclusion approach:</strong> A/T and G/C SNPs explicitly excluded</li><li><strong>Frequency-based inference:</strong> Allele frequencies used to determine strand alignment with frequency threshold stated (e.g., MAF &lt; 0.42 or 0.45)</li><li><strong>Reference-based alignment: </strong>Use of reference panel allele frequencies for alignment</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Palindromic SNPs not mentioned</li><li>Handled but method not specified</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>Single-sample MR study</li></ul></td></tr><tr><td><p><strong>A7</strong></p></td><td><p><strong>Sample Overlap</strong></p></td><td><p>Is sample overlap between exposure and outcome GWAS appropriately addressed?</p></td><td><p><strong>For 2-sample MR - Score 1 if:</strong></p><ul><li>Sample overlap explicitly discussed (even if stated as ‚Äúnone‚Äù or ‚Äúminimal‚Äù)</li><li>Overlap quantified when present (e.g., ‚Äú15% overlap‚Äù)</li><li>Appropriate methods used when overlap exists (e.g., CAUSE, MR-RAPS adjustment)</li></ul><p><strong>For 1-sample MR - Score 1 if:</strong></p><ul><li>Two-stage least squares (2SLS) or equivalent method used</li><li>Appropriate software mentioned (e.g., ivreg, ivpack)</li><li>Method justification provided for using same sample</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Sample overlap not mentioned in 2-sample MR</li><li>1-sample MR without appropriate statistical method</li></ul></td></tr><tr><td><p><strong>A8</strong></p></td><td><p><strong>Confounder Control</strong></p></td><td><p>Are limitations of confounder control acknowledged (2-sample) or covariates appropriately controlled (1-sample)?</p></td><td><p><strong>For 2-sample MR - Score 1 if:</strong></p><ul><li>Explicit acknowledgment that individual-level covariates cannot be controlled</li><li>Discussion of residual confounding as study limitation</li><li>Population stratification control mentioned (if applicable)</li></ul><p><strong>For 1-sample MR - Score 1 if:</strong></p><ul><li>Covariate adjustment clearly described</li><li>Standard covariates included: age, sex, principal components</li><li>Method for covariate selection described</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No discussion of confounder control limitations (2-sample)</li><li>No covariate adjustment described (1-sample)</li></ul></td></tr><tr><td><p><strong>A9</strong></p></td><td><p><strong>Outlier Detection</strong></p></td><td><p>Are outlier instruments identified using systematic methods and sensitivity analysis performed?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>Outlier detection method applied: Any systematic approach (leave-one-out analysis, radial MR, Cook\\'s distance, MVMR-cML)</li><li>Method clearly named: Specific technique identified, not just ‚Äúoutlier analysis‚Äù</li><li>Sensitivity analysis: Results presented both with and without identified outliers</li><li>Impact discussed: Effect of outlier removal on estimates reported</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No systematic outlier detection</li><li>Method not specified</li><li>No sensitivity analysis performed</li></ul></td></tr><tr><td><p><strong>A10</strong></p></td><td><p><strong>Sensitivity Analyses</strong></p></td><td><p>Are pleiotropy or heterogeneity assessed using appropriate statistical tests?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following methods applied with results reported:&lt;br/&gt;‚Ä¢</strong></p><ul><li>MR-Egger regression: Intercept and slope reported with p-values</li><li>Weighted median: Estimates and confidence intervals provided</li><li>MR-PRESSO: Global test and outlier correction results</li><li>Heterogeneity tests: Cochran\\'s Q test with p-value and I¬≤ statistic</li><li>Radial MR: Modified Q-statistic and outlier identification</li><li>Contamination mixture methods: MR-Mix, CAUSE, or similar</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Methods mentioned but results not provided</li><li>Only theoretical discussion of pleiotropy</li><li>No statistical testing performed</li></ul></td></tr><tr><td><p><strong>A11a</strong></p></td><td><p><strong>Robust Estimators - Use</strong></p></td><td><p>Are alternative estimators beyond inverse-variance weighted (IVW) used?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>At least one additional estimator beyond IVW used from: Weighted median, Weighted mode, MR-Egger, MR-RAPS, GSMR, or other validated methods</li><li>Results for additional estimators reported with confidence intervals</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only IVW method used</li><li>Additional methods mentioned but results not reported</li></ul></td></tr><tr><td><p><strong>A11b</strong></p></td><td><p><strong>Robust Estimators - Results</strong></p></td><td><p>Are results consistent across multiple estimators?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>Multiple estimators used AND results consistent across methods with explicit comparison</li><li>Discordant results appropriately discussed with potential explanations</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Results are inconsistent</li><li>Results are not compared</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>Only one estimator used</li></ul></td></tr><tr><td><p><strong>A12</strong></p></td><td><p><strong>Statistical Power</strong></p><p><strong>[NEW ITEM]</strong></p></td><td><p>Is statistical power assessed or sample size adequately justified for detecting clinically relevant effects?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li><strong>Formal power calculation: </strong>Statistical power calculated using R¬≤ and sample sizes</li><li><strong>Minimum detectable effect size:</strong> Calculated and reported (e.g., ‚Äú80% power to detect OR &gt; 1.15‚Äù)</li><li><strong>Sample size justification:</strong> Discussion of adequacy relative to expected effect sizes</li><li><strong>Power calculation software/formula referenced: </strong>mRnd, Mendelian randomization power calculator, or formula citation</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No power assessment</li><li>Only general statements about ‚Äúlarge sample sizes‚Äù</li></ul></td></tr></tbody></table>\\n\\n#### Additional Quality Indicators\\n\\n**Critical Items for Study Validity** (Must score 1 for minimum quality):\\n\\n- A1 (Data Sources)\\n- A2 (Instrument Selection)\\n- A3 (Instrument Strength - must not score -1)\\n- A9 (Outlier Detection)\\n- A10 (Sensitivity Analyses)\\n\\n**Methodological Rigor Indicators** (Items that distinguish high-quality studies):\\n\\n- A4 (MR Assumptions empirical testing)\\n- A11 (Multiple robust estimators)\\n- A12 (Statistical power assessment)\\n\\n#### Overall Part A Quality Assessment\\n\\n**High Quality Core Methods:** ‚â•85% of applicable items scored ‚â•1, with all critical items = 1\\n\\n**Moderate Quality:** 70-84% of applicable items scored ‚â•1\\n\\n**Low Quality:** <70% of applicable items scored ‚â•1 OR any critical item = 0\\n\\n### Part B: Cross-Ancestry Extensions to MR Methodology\\n\\n**Scoring Instructions**:\\n\\n- **0 = Not Addressed**: Item missing or not discussed anywhere in paper\\n- **1 = Fully Addressed**: Item explicitly addressed with required elements present\\n- **N/A**: Item clearly not applicable to study design\\n- **Specific numeric thresholds and keywords are provided below to minimize reviewer interpretation**\\n\\n<table><tbody><tr><th><p><strong>Item</strong></p></th><th><p><strong>Category</strong></p></th><th><p><strong>Question</strong></p></th><th><p><strong>Evaluation Criteria</strong></p></th></tr><tr><td><p><strong>B1</strong></p></td><td><p><strong>Ancestry Reporting</strong></p></td><td><p>Are ancestries of Exposure and Outcome GWAS explicitly reported with sample composition details?</p></td><td><p><strong>Score 1 if ALL of the following are present:</strong></p><ul><li>Ancestry of exposure GWAS explicitly stated using standard terms (European, East Asian, African, South Asian, Hispanic/Latino, Native American, Oceanian, or specific population names)</li><li>Ancestry of outcome GWAS explicitly stated using same terminology</li><li>For multi-ancestry GWAS: numerical breakdown provided (e.g., \"80% European, 15% East Asian, 5% African\" OR sample sizes per ancestry group)</li><li>For admixed populations: either ancestry proportions OR population-specific labels (e.g., \"African American,\" \"Hispanic/Latino\")</li></ul><p><strong>Score 0 if ANY of the following:</strong></p><ul><li>Ancestry described only as \"diverse,\" \"mixed,\" or \"multi-ethnic\" without specifics</li><li>Missing ancestry information for either exposure or outcome GWAS</li><li>Multi-ancestry GWAS mentioned without numerical breakdown</li></ul></td></tr><tr><td><p><strong>B2</strong></p></td><td><p><strong>Cross-Ancestry Harmonization</strong></p></td><td><p>Are exposure and outcome GWAS ancestry-matched, or is ancestry mismatch explicitly tested?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li>Both exposure and outcome GWAS use identical ancestry populations (e.g., both European-only)</li><li>Cross-ancestry analysis with explicit testing: stratified analysis by ancestry reported</li><li>Replication performed in matched ancestry groups</li><li>Formal heterogeneity testing across ancestry groups with results discussed</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Exposure and outcome GWAS use different ancestries without any testing or justification</li><li>Authors acknowledge mismatch but provide no empirical evaluation</li></ul></td></tr><tr><td><p><strong>B3</strong></p></td><td><p><strong>LD Structure Compatibility</strong></p></td><td><p>Is ancestry-appropriate LD reference panel used for instrument selection and pruning?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>LD reference panel explicitly named (e.g., \"1000 Genomes Phase 3 EUR,\" \"gnomAD v3.1 EAS\")</li><li>Reference panel ancestry matches GWAS ancestry for instrument selection</li><li>LD pruning parameters stated (r¬≤ threshold, window size)</li><li>For multi-ancestry: either ancestry-specific panels used OR justification for single panel provided</li></ul><p><strong>Score 0 if ANY missing:</strong></p><ul><li>LD reference panel not named</li><li>Clear ancestry mismatch between panel and GWAS</li><li>LD parameters not specified</li></ul></td></tr><tr><td><p><strong>B4</strong></p></td><td><p><strong>Ancestry-Specific Instrument Strength</strong></p></td><td><p>Is instrument strength evaluated separately for each ancestry group?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>F-statistics OR R¬≤ reported separately for each ancestry in exposure GWAS</li><li>For single-ancestry exposure with multi-ancestry outcome: strength metrics calculated using ancestry-matched exposure data</li><li>Weak instrument bias discussed in context of ancestry-specific effects</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only pooled/overall instrument strength reported</li><li>Ancestry-specific strength not evaluated despite multi-ancestry data</li></ul></td></tr><tr><td><p><strong>B5</strong></p></td><td><p><strong>Allele Frequency Validation</strong></p></td><td><p>Are minor allele frequencies (MAF) reported and appropriate thresholds applied per ancestry?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>MAF thresholds explicitly stated (e.g., \"MAF &gt; 0.01,\" \"MAF &gt; 0.05\")</li><li>MAF filtering applied separately by ancestry OR ancestry-specific MAF values reported</li><li>Number of SNPs excluded due to low MAF reported by ancestry group (if applicable)</li></ul><p><strong>Score 0 if:</strong></p><ul><li>MAF thresholds not specified</li><li>Only pooled MAF filtering without ancestry consideration</li><li>MAF information completely absent</li></ul></td></tr><tr><td><p><strong>B6</strong></p></td><td><p><strong>Instrument Transferability</strong></p></td><td><p>Is the validity of applying genetic instruments across ancestries explicitly justified?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following:</strong></p><ul><li><strong>Empirical replication:</strong> MR analysis replicated in target ancestry with results compared</li><li><strong>LD/frequency comparison:</strong> Explicit comparison of instrument LD patterns or allele frequencies across ancestries with data shown</li><li><strong>Biological justification:</strong> Stated rationale for cross-ancestry generalizability referencing conserved biological pathways, gene function, or mechanistic studies</li><li><strong>Literature support: </strong>Citations to studies demonstrating cross-ancestry validity of specific instruments used</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No justification provided for cross-ancestry instrument application</li><li>Only general statements about genetic similarity without specific evidence</li><li>Transferability assumed without discussion</li></ul></td></tr><tr><td><p><strong>B7</strong></p></td><td><p><strong>Phenotype Consistency</strong></p></td><td><p>Are exposure and outcome phenotypes defined consistently across ancestry groups?</p></td><td><p><strong>Score 1 if ALL applicable elements present:</strong></p><p><strong><em>For binary traits:</em></strong></p><ul><li>Identical diagnostic criteria across ancestries (e.g., same ICD codes, clinical thresholds)</li><li>Case/control definitions explicitly stated for each ancestry</li></ul><p><strong><em>For continuous traits:</em></strong></p><ul><li>Measurement units consistent across ancestries (e.g., all BMI in kg/m¬≤)</li><li>Standardization methods described if units differ</li><li>Transformation procedures (log, inverse-normal) applied consistently</li></ul><p><strong>Score 0 if ANY of the following:</strong></p><ul><li>Different diagnostic criteria used across ancestries without harmonization</li><li>Measurement units inconsistent without conversion</li><li>Phenotype definitions not specified for one or more ancestry groups</li></ul></td></tr><tr><td><p><strong>B8</strong></p></td><td><p><strong>Ancestry-Stratified Analysis</strong></p></td><td><p>Are MR results reported by ancestry and/or tested for heterogeneity across ancestry groups?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following:</strong></p><ul><li>Stratified results: MR estimates reported separately for each ancestry with effect sizes and confidence intervals</li><li>Formal heterogeneity testing: Cochran\\'s Q, I¬≤, or similar tests performed across ancestries with p-values and interpretation</li><li>Meta-analysis approach: Random/fixed effects meta-analysis across ancestry groups with heterogeneity assessment</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only pooled results reported without ancestry breakdown</li><li>Heterogeneity mentioned but not formally tested</li><li>Results combined across ancestries without consideration of differences</li></ul></td></tr><tr><td><p><strong>B9</strong></p></td><td><p><strong>Colocalization Analysis</strong></p></td><td><p>Is colocalization or fine-mapping used to assess whether instruments tag the same causal variants across ancestries?</p></td><td><p><strong>Score 1 if ANY of the following methods applied:</strong></p><ul><li><strong>Formal colocalization:</strong> COLOC, eCAVIAR, or similar methods with posterior probabilities reported</li><li><strong>Fine-mapping comparison:</strong> SuSiE, FINEMAP, or credible sets compared across ancestries</li><li><strong>Lead SNP analysis:</strong> Assessment of whether lead SNPs are identical or in high LD (r¬≤ &gt; 0.8) across ancestries</li><li><strong>Conditional analysis:</strong> Testing whether signals remain after conditioning on lead variants</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No assessment of variant-level concordance across ancestries</li><li>Only mentions colocalization without formal analysis</li></ul></td></tr><tr><td><p><strong>B10</strong></p></td><td><p><strong>Ancestry-Specific Pleiotropy</strong></p></td><td><p>Does the study evaluate whether SNP-outcome associations differ across ancestries independently of the exposure?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following:</strong></p><ul><li>Ancestry-stratified pleiotropy tests: MR-Egger intercepts, MR-PRESSO, or radial MR performed separately by ancestry with results compared</li><li>Confounder testing by ancestry: Instruments tested for association with known confounders in each ancestry group separately</li><li>Pathway analysis: Discussion of ancestry-specific biological pathways or gene expression differences that could affect pleiotropy</li><li>Negative control analysis: Testing instruments against negative control outcomes in each ancestry</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only pooled pleiotropy testing without ancestry stratification</li><li>Pleiotropy discussed generally without ancestry-specific evaluation</li></ul></td></tr><tr><td><p><strong>B11</strong></p></td><td><p><strong>Population Stratification</strong></p><p><strong>[NEW ITEM]</strong></p></td><td><p>Are population stratification and cryptic relatedness adequately controlled within and across ancestry groups?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>Principal components (PCs) inclusion explicitly stated with number of PCs reported</li><li>Genomic control (Œª) values reported and appropriate (Œª &lt; 1.1 preferred, Œª &lt; 1.2 acceptable)</li><li>For multi-ancestry analysis: either ancestry-specific PC calculation OR justified approach for combined analysis</li><li>Relatedness filtering described (e.g., IBD &lt; 0.05, kinship thresholds)</li></ul><p><strong>Score 0 if ANY missing:</strong></p><ul><li>PC adjustment not mentioned</li><li>Genomic control not reported or Œª &gt; 1.2</li><li>No relatedness filtering described</li></ul></td></tr><tr><td><p><strong>B12</strong></p></td><td><p><strong>Effect Size Interpretation</strong></p><p><strong>[NEW ITEM]</strong></p></td><td><p>Are effect sizes interpreted appropriately considering ancestry-specific baseline risks and phenotype distributions?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>Authors acknowledge potential differences in baseline risk/phenotype distributions across ancestries</li><li>Effect sizes discussed in context of ancestry-specific clinical relevance</li><li>Absolute risk differences calculated or discussed where appropriate</li><li>Limitations regarding generalizability of effect sizes across populations mentioned</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Effect sizes interpreted identically across ancestries without consideration of population differences</li><li>No discussion of clinical relevance by ancestry</li></ul></td></tr></tbody></table>\\n\\n#### Additional Scoring Guidelines\\n\\n**For Multi-Ancestry Studies:** All items in Part B are applicable\\n\\n**For Cross-Ancestry Studies (exposure and outcome from different ancestries):** Items B2, B6, B7, B10, B12 are particularly critical\\n\\n**For Single-Ancestry Studies with Multi-Ancestry GWAS:** Items B1, B3, B4, B5, B11 apply\\n\\n#### Quality Thresholds for Overall Assessment\\n\\n**High Quality Cross-Ancestry Methods:** ‚â•80% of applicable Part B items scored as 1\\n\\n**Moderate Quality:** 60-79% of applicable Part B items scored as 1\\n\\n**Low Quality:** <60% of applicable Part B items scored as 1', last_error=LastError(code='rate_limit_exceeded', message='You exceeded your current quota, please check your plan and billing details. For more information on this error, read the docs: https://platform.openai.com/docs/guides/error-codes/api-errors.'), max_completion_tokens=None, max_prompt_tokens=None, metadata={}, model='gpt-3.5-turbo', object='thread.run', parallel_tool_calls=True, required_action=None, response_format='auto', started_at=1751503380, status='failed', thread_id='thread_dmtgnCOKBocZg4YFzK45VTBb', tool_choice='auto', tools=[FileSearchTool(type='file_search', file_search=FileSearch(max_num_results=None, ranking_options={'ranker': 'default_2024_08_21', 'score_threshold': 0.0}))], truncation_strategy=TruncationStrategy(type='auto', last_messages=None), usage=Usage(completion_tokens=0, prompt_tokens=0, total_tokens=0, prompt_token_details={'cached_tokens': 0}, completion_tokens_details={'reasoning_tokens': 0}), temperature=1.0, top_p=1.0, tool_resources={}, reasoning_effort=None)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    },
    {
     "ename": "RuntimeError",
     "evalue": "Run failed on part1",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mRuntimeError\u001b[0m                              Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[1], line 335\u001b[0m\n\u001b[0;32m    333\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m i, pdf_file \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28menumerate\u001b[39m(tqdm(pdf_files, desc\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mProcessing PDFs\u001b[39m\u001b[38;5;124m\"\u001b[39m), \u001b[38;5;241m1\u001b[39m):\n\u001b[0;32m    334\u001b[0m     pdf_path \u001b[38;5;241m=\u001b[39m os\u001b[38;5;241m.\u001b[39mpath\u001b[38;5;241m.\u001b[39mjoin(pdf_dir, pdf_file)\n\u001b[1;32m--> 335\u001b[0m     result \u001b[38;5;241m=\u001b[39m \u001b[43mprocess_pdf\u001b[49m\u001b[43m(\u001b[49m\u001b[43mpdf_path\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mi\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    336\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m result:\n\u001b[0;32m    337\u001b[0m         results\u001b[38;5;241m.\u001b[39mappend(result)\n",
      "Cell \u001b[1;32mIn[1], line 315\u001b[0m, in \u001b[0;36mprocess_pdf\u001b[1;34m(file_path, index)\u001b[0m\n\u001b[0;32m    308\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m extract_json_objects(response_text)\n\u001b[0;32m    310\u001b[0m     \u001b[38;5;66;03m# except Exception as e:\u001b[39;00m\n\u001b[0;32m    311\u001b[0m     \u001b[38;5;66;03m#     print(f\"[ERROR][{index}] Failed during '{label}' for {file_name}:\\n{e}\")\u001b[39;00m\n\u001b[0;32m    312\u001b[0m     \u001b[38;5;66;03m#     return None\u001b[39;00m\n\u001b[0;32m    313\u001b[0m \n\u001b[0;32m    314\u001b[0m \u001b[38;5;66;03m# Run both prompts and combine results\u001b[39;00m\n\u001b[1;32m--> 315\u001b[0m data1 \u001b[38;5;241m=\u001b[39m \u001b[43mrun_prompt\u001b[49m\u001b[43m(\u001b[49m\u001b[43mrubric_prompt_1\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mpart1\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m)\u001b[49m\n\u001b[0;32m    316\u001b[0m data2 \u001b[38;5;241m=\u001b[39m run_prompt(rubric_prompt_2, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mpart2\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[0;32m    318\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m data1 \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m data2:\n",
      "Cell \u001b[1;32mIn[1], line 295\u001b[0m, in \u001b[0;36mprocess_pdf.<locals>.run_prompt\u001b[1;34m(prompt, label)\u001b[0m\n\u001b[0;32m    293\u001b[0m     \u001b[38;5;28;01melif\u001b[39;00m run_status\u001b[38;5;241m.\u001b[39mstatus \u001b[38;5;241m==\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mfailed\u001b[39m\u001b[38;5;124m\"\u001b[39m:\n\u001b[0;32m    294\u001b[0m         \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mStatus info: \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mrun_status\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m--> 295\u001b[0m         \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mRuntimeError\u001b[39;00m(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mRun failed on \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mlabel\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m)\n\u001b[0;32m    296\u001b[0m     time\u001b[38;5;241m.\u001b[39msleep(\u001b[38;5;241m1\u001b[39m)\n\u001b[0;32m    298\u001b[0m messages \u001b[38;5;241m=\u001b[39m client\u001b[38;5;241m.\u001b[39mbeta\u001b[38;5;241m.\u001b[39mthreads\u001b[38;5;241m.\u001b[39mmessages\u001b[38;5;241m.\u001b[39mlist(thread_id\u001b[38;5;241m=\u001b[39mthread\u001b[38;5;241m.\u001b[39mid)\n",
      "\u001b[1;31mRuntimeError\u001b[0m: Run failed on part1"
     ]
    }
   ],
   "source": [
    "rubric_prompt_1 = \"\"\"I am conducting a Methods Audit of Mendelian Randomization (MR) studies using a study characteristics form and a structured scoring rubric. I will upload the MR study as a PDF file.\n",
    "\n",
    "Please use the attached study characteristics form to extract the relevant data from the MR study.\n",
    "\n",
    "**Notes:**\n",
    "- If any item is unclear or cannot be determined from the study, mark it as N/A and briefly explain why.\n",
    "\n",
    "# Study Characteristics Form \n",
    "\n",
    "| **Label** | **Field** | **Question** |\n",
    "| --- | --- | --- |\n",
    "| Q1  | Study ID | What is the study‚Äôs citation shorthand (first author and publication year, e.g. Storm 2023)? |\n",
    "| Q2  | Study Title | What is the full title of the article? |\n",
    "| Q3  | Journal | What is the full name of the journal in which the article was published? |\n",
    "| Q4  | Publication Year | In what year was the article published? |\n",
    "| Q5  | Study Design / MR Type | What type(s) of MR design(s) were used? (e.g. One-sample MR, Two-sample MR, Multivariable MR, Bidirectional MR, or combinations) |\n",
    "| Q6  | Instrumental Variable(s) | What types of genetic instruments were used (e.g. GWAS SNPs, cis-variants, PRS)? If SNPs were LD-clumped, what were the clumping parameters (e.g. r¬≤ threshold, physical distance window)? |\n",
    "| Q7  | Number of SNPs per Exposure | How many SNPs were used for each exposure? Report counts separately for each exposure and ancestry group.<br><br>Example: BMI: 62 SNPs (EAS), 298 SNPs (EUR); CRP: 6 SNPs (EAS), 183 SNPs (EUR); HDL-C: 50 SNPs (EAS), 247 SNPs (EUR); BS: 15 SNPs (EAS), 93 SNPs (EUR); TGs: 36 SNPs (EAS), 204 SNPs (EUR); SBP: 22 SNPs (EAS), 158 SNPs (EUR) |\n",
    "| Q8  | Exposure(s) | What traits, biomarkers, or risk factors were analyzed as exposures? |\n",
    "| Q9  | Outcome(s) | What traits, diseases, or phenotypes were analyzed as outcomes? |\n",
    "| Q10 | Number of Exposures Assessed | How many distinct exposures were included? |\n",
    "| Q11 | Number of Outcomes Assessed | How many distinct outcomes were assessed? |\n",
    "| Q12 | GWAS Source for Exposure(s) | What GWAS datasets or consortia provided SNP‚Äìexposure associations? List all.<br><br>Example: ALT/AST: UK Biobank (Neale Lab); NAFLD liability: Million Veteran Program; liver MRI: UK Biobank subset; East Asian: Biobank Japan |\n",
    "| Q13 | GWAS Source for Outcome(s) | What GWAS datasets or consortia provided SNP‚Äìoutcome associations? List all.<br><br>Example: CAD: CARDIoGRAM; stroke: MEGASTROKE; atrial fibrillation: published GWAS; heart failure: HERMES consortium; T2D: DIAMANTE consortium; glycaemic traits: MAGIC; East Asian: Biobank Japan, AGEN consortium |\n",
    "| Q14 | Sample Size for Exposure(s) | What was the total sample size for each exposure dataset, including cases and controls if applicable? |\n",
    "| Q15 | Sample Size for Outcome(s) | What was the total sample size for each outcome dataset, including cases and controls if applicable? |\n",
    "| Q16 | Ancestries Represented in Exposure GWAS | What ancestry groups were included in the exposure GWAS (e.g. European, East Asian)? |\n",
    "| Q17 | Ancestries Represented in Outcome GWAS | What ancestry groups were included in the outcome GWAS? |\n",
    "| Q18 | Separate MR Analyses by Ancestry | Did the study conduct ancestry-stratified MR analyses? (Yes/No) |\n",
    "| Q19 | Geographic Region(s) Represented | What geographic regions or countries were the study populations drawn from |\n",
    "| Q20 | Software Used | What statistical software, packages, or MR tools were used (e.g. R, Stata, TwoSampleMR, MR-Base, GSMR, LDSC)? |\n",
    "\n",
    "\n",
    "**Example Output Format**\n",
    "Return only a single structured JSON object with the following format. Do not include any explanations, notes, or additional text.\n",
    "\n",
    "```json\n",
    "{\n",
    "    \"Q1\": \"...\",\n",
    "    \"Q2\": \"...\",\n",
    "    \"Q3\": \"...\",\n",
    "    \"...\": \"...\",\n",
    "    \"Q20\": \"...\"\n",
    "}\n",
    "```\n",
    "\"\"\"\n",
    "\n",
    "\n",
    "rubric_prompt_2 = \"\"\"I am conducting a Methods Audit of Mendelian Randomization (MR) studies using a study characteristics form and a structured scoring rubric. I will upload the MR study as a PDF file.\n",
    "\n",
    "Please use the attached rubric (Parts A and B) to score the MR study.\n",
    "\n",
    "- Score each item as 0, 1, or N/A based on the rubric's detailed evaluation criteria.\n",
    "\n",
    "**Output Format (JSON)**\n",
    "\n",
    "Return only a single structured JSON object with the following three components. Do not include any explanations, notes, or additional text.\n",
    "\n",
    "1. **scoring  \n",
    "    Includes scores for each rubric item in Part A (A1‚ÄìA12) and Part B (B1‚ÄìB12), using 0, 1, or \"N/A\".**\n",
    "2. **evidence  \n",
    "    For each item in A1‚ÄìA12 and B1‚ÄìB12, include:**\n",
    "    - **score: the assigned value (0, 1, or \"N/A\")**\n",
    "    - **quote: verbatim excerpt from the paper**\n",
    "    - **section: the section where the quote was found (e.g., \"Methods\", \"Results\")**\n",
    "\n",
    "**Use the PDF file name as the value for study_id.**\n",
    "\n",
    "**Example Output Format**\n",
    "```json\n",
    "{\n",
    "  \"scoring\": {\n",
    "    \"A\": {\n",
    "      \"A1\": 1,\n",
    "      \"A2\": 0,\n",
    "      \"...\": \"N/A\"\n",
    "        // Continue for all A items\n",
    "    },\n",
    "    \"B\": {\n",
    "      \"B1\": 1,\n",
    "      \"B2\": 0,\n",
    "      \"...\": \"N/A\"\n",
    "        // Continue for all B items\n",
    "    }\n",
    "  },\n",
    "  \"evidence\": {\n",
    "    \"A\": {\n",
    "      \"A1\": {\n",
    "        \"score\": 1,\n",
    "        \"quote\": \"...verbatim text from paper...\",\n",
    "        \"section\": \"Methods ‚Äì Instrument Selection\"\n",
    "      },\n",
    "      \"A2\": {\n",
    "        \"score\": 0,\n",
    "        \"quote\": \"N/A\",\n",
    "        \"section\": \"N/A\"\n",
    "      }\n",
    "        // Continue for all A items\n",
    "    },\n",
    "    \"B\": {\n",
    "      \"B1\": {\n",
    "        \"score\": 1,\n",
    "        \"quote\": \"...\",\n",
    "        \"section\": \"Results ‚Äì Sample Characteristics\"\n",
    "      }\n",
    "        // Continue for all B items\n",
    "    }\n",
    "  }\n",
    "}\n",
    "```\n",
    "\n",
    "**Notes:**\n",
    "\n",
    "- Follow the rubric‚Äôs critical item and quality threshold rules if applicable.\n",
    "- If any item is unclear or cannot be determined from the study, mark it as N/A and briefly explain why.\n",
    "\n",
    "# Scoring Rubric\n",
    "\n",
    "### Part A: Core MR Methodology\n",
    "\n",
    "**Scoring Instructions**:\n",
    "\n",
    "- **0 = Not Addressed**: Item missing or not discussed anywhere in paper\n",
    "- **1 = Fully Addressed**: Item explicitly addressed with required elements present\n",
    "- **N/A**: Item clearly not applicable to study design\n",
    "- **Specific numeric thresholds and keywords are provided below to minimize reviewer interpretation**\n",
    "\n",
    "<table><tbody><tr><th><p><strong>Item</strong></p></th><th><p><strong>Category</strong></p></th><th><p><strong>Question</strong></p></th><th><p><strong>Evaluation Criteria</strong></p></th></tr><tr><td><p><strong>A1</strong></p></td><td><p><strong>Data Sources</strong></p></td><td><p>Are Exposure and Outcome GWAS described with source, ancestry, and sample size?</p></td><td><p><strong>Score 1 if ALL of the following for BOTH exposure and outcome GWAS:</strong></p><ul><li>Source identification: Study name (e.g., ‚ÄúUK Biobank‚Äù), consortium (e.g., ‚ÄúGIANT‚Äù), or specific cohort clearly stated</li><li>Sample size: Total N provided as specific number (not ranges like ‚Äú~500,000‚Äù)</li><li>Ancestry composition: Population ancestry explicitly stated using standard terms or percentages</li></ul><p><strong>Score 0 if ANY element missing or vague:</strong></p><ul><li>Source described only as ‚Äúpublished GWAS‚Äù or ‚Äúlarge-scale study‚Äù</li><li>Sample size missing, unclear, or given as approximation</li><li>Ancestry not specified or described only as ‚Äúmixed‚Äù without detail</li></ul></td></tr><tr><td><p><strong>A2</strong></p></td><td><p><strong>Instrument Selection</strong></p></td><td><p>Are SNP instruments selected using genome-wide significance and LD pruning/clumping with parameters specified?</p></td><td><p><strong>Score 1 if ALL of the following criteria present:</strong></p><ul><li>Genome-wide significance: p &lt; 5√ó10‚Åª‚Å∏ threshold explicitly stated</li><li>LD pruning/clumping: Method clearly specified (pruning OR clumping)</li><li>LD parameters: r¬≤ threshold stated (e.g., r¬≤ &lt; 0.001, r¬≤ &lt; 0.01)</li><li>Distance parameter: Window size specified (e.g., 1MB, 250kb, 10,000kb)</li><li>Reference panel: LD reference panel named (e.g., ‚Äú1000 Genomes Phase 3‚Äù)</li></ul><p><strong>Score 0 if ANY of the following:</strong></p><ul><li>Different p-value threshold used (e.g., p &lt; 5√ó10‚Åª‚Å∂) without justification</li><li>LD method not specified (‚Äúindependent SNPs‚Äù without method)</li><li>Parameters missing (r¬≤ or distance threshold not provided)</li><li>Reference panel not identified</li></ul></td></tr><tr><td><p><strong>A3a</strong></p></td><td><p><strong>Instrument Strength - Reporting</strong></p></td><td><p>Is instrument strength reported using F-statistics or R¬≤?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li>F-statistics provided with values (per instrument OR mean F-statistic)</li><li>R¬≤ (variance explained) provided as percentage or proportion</li><li>Both F-statistics and R¬≤ reported</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Strength mentioned but no values provided (e.g., ‚Äústrong instruments‚Äù)</li><li>Only weak instrument bias mentioned without metrics</li><li>No mention of instrument strength</li></ul></td></tr><tr><td><p><strong>A3b</strong></p></td><td><p><strong>Instrument Strength - Adequacy</strong></p></td><td><p>If F-statistics reported, are they adequate (F ‚â• 10)?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>F ‚â• 10</li></ul><p><strong>Score 0 if:</strong></p><ul><li>F &lt; 10</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>F-statistics not reported</li></ul></td></tr><tr><td><p><strong>A4</strong></p></td><td><p><strong>MR Assumptions</strong></p></td><td><p>Are the three core IV assumptions explicitly stated and at least one empirically evaluated?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li><strong>All three assumptions named: </strong>Relevance (instrument-exposure association), Independence (no confounding), Exclusion restriction (no pleiotropy)</li><li><strong>At least one assumption empirically tested</strong> using ANY of:</li><li>Confounder association testing (PhenoScanner, manual curation)</li><li>Known confounder control testing</li><li>Pleiotropy detection methods (MR-Egger, MR-PRESSO)</li><li>Negative control analyses</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Assumptions mentioned but not all three clearly identified</li><li>No empirical evaluation of any assumption</li><li>Only theoretical discussion without testing</li></ul></td></tr><tr><td><p><strong>A5</strong></p></td><td><p><strong>Harmonization</strong></p></td><td><p>Are effect alleles harmonized and strand alignment issues addressed between datasets?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following approaches clearly described:</strong></p><ul><li><strong>Automated harmonization: </strong>Use of harmonization functions/packages (e.g., TwoSampleMR harmonise_data(), MungeSumstats)</li><li><strong>Manual harmonization: </strong>Process for aligning effect alleles described with specific steps</li><li><strong>Strand flip handling:</strong> Explicit mention of identifying and correcting strand flips</li><li><strong>Ambiguous SNP removal: </strong>A/T and G/C SNPs excluded or handled with frequency-based inference</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No mention of harmonization procedures</li><li>Only states ‚Äúdata were harmonized‚Äù without method description</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>Single-sample MR study</li></ul></td></tr><tr><td><p><strong>A6</strong></p></td><td><p><strong>Palindromic SNPs</strong></p></td><td><p>Are palindromic (A/T, G/C) SNPs handled appropriately?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li><strong>Exclusion approach:</strong> A/T and G/C SNPs explicitly excluded</li><li><strong>Frequency-based inference:</strong> Allele frequencies used to determine strand alignment with frequency threshold stated (e.g., MAF &lt; 0.42 or 0.45)</li><li><strong>Reference-based alignment: </strong>Use of reference panel allele frequencies for alignment</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Palindromic SNPs not mentioned</li><li>Handled but method not specified</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>Single-sample MR study</li></ul></td></tr><tr><td><p><strong>A7</strong></p></td><td><p><strong>Sample Overlap</strong></p></td><td><p>Is sample overlap between exposure and outcome GWAS appropriately addressed?</p></td><td><p><strong>For 2-sample MR - Score 1 if:</strong></p><ul><li>Sample overlap explicitly discussed (even if stated as ‚Äúnone‚Äù or ‚Äúminimal‚Äù)</li><li>Overlap quantified when present (e.g., ‚Äú15% overlap‚Äù)</li><li>Appropriate methods used when overlap exists (e.g., CAUSE, MR-RAPS adjustment)</li></ul><p><strong>For 1-sample MR - Score 1 if:</strong></p><ul><li>Two-stage least squares (2SLS) or equivalent method used</li><li>Appropriate software mentioned (e.g., ivreg, ivpack)</li><li>Method justification provided for using same sample</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Sample overlap not mentioned in 2-sample MR</li><li>1-sample MR without appropriate statistical method</li></ul></td></tr><tr><td><p><strong>A8</strong></p></td><td><p><strong>Confounder Control</strong></p></td><td><p>Are limitations of confounder control acknowledged (2-sample) or covariates appropriately controlled (1-sample)?</p></td><td><p><strong>For 2-sample MR - Score 1 if:</strong></p><ul><li>Explicit acknowledgment that individual-level covariates cannot be controlled</li><li>Discussion of residual confounding as study limitation</li><li>Population stratification control mentioned (if applicable)</li></ul><p><strong>For 1-sample MR - Score 1 if:</strong></p><ul><li>Covariate adjustment clearly described</li><li>Standard covariates included: age, sex, principal components</li><li>Method for covariate selection described</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No discussion of confounder control limitations (2-sample)</li><li>No covariate adjustment described (1-sample)</li></ul></td></tr><tr><td><p><strong>A9</strong></p></td><td><p><strong>Outlier Detection</strong></p></td><td><p>Are outlier instruments identified using systematic methods and sensitivity analysis performed?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>Outlier detection method applied: Any systematic approach (leave-one-out analysis, radial MR, Cook's distance, MVMR-cML)</li><li>Method clearly named: Specific technique identified, not just ‚Äúoutlier analysis‚Äù</li><li>Sensitivity analysis: Results presented both with and without identified outliers</li><li>Impact discussed: Effect of outlier removal on estimates reported</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No systematic outlier detection</li><li>Method not specified</li><li>No sensitivity analysis performed</li></ul></td></tr><tr><td><p><strong>A10</strong></p></td><td><p><strong>Sensitivity Analyses</strong></p></td><td><p>Are pleiotropy or heterogeneity assessed using appropriate statistical tests?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following methods applied with results reported:&lt;br/&gt;‚Ä¢</strong></p><ul><li>MR-Egger regression: Intercept and slope reported with p-values</li><li>Weighted median: Estimates and confidence intervals provided</li><li>MR-PRESSO: Global test and outlier correction results</li><li>Heterogeneity tests: Cochran's Q test with p-value and I¬≤ statistic</li><li>Radial MR: Modified Q-statistic and outlier identification</li><li>Contamination mixture methods: MR-Mix, CAUSE, or similar</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Methods mentioned but results not provided</li><li>Only theoretical discussion of pleiotropy</li><li>No statistical testing performed</li></ul></td></tr><tr><td><p><strong>A11a</strong></p></td><td><p><strong>Robust Estimators - Use</strong></p></td><td><p>Are alternative estimators beyond inverse-variance weighted (IVW) used?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>At least one additional estimator beyond IVW used from: Weighted median, Weighted mode, MR-Egger, MR-RAPS, GSMR, or other validated methods</li><li>Results for additional estimators reported with confidence intervals</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only IVW method used</li><li>Additional methods mentioned but results not reported</li></ul></td></tr><tr><td><p><strong>A11b</strong></p></td><td><p><strong>Robust Estimators - Results</strong></p></td><td><p>Are results consistent across multiple estimators?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>Multiple estimators used AND results consistent across methods with explicit comparison</li><li>Discordant results appropriately discussed with potential explanations</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Results are inconsistent</li><li>Results are not compared</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>Only one estimator used</li></ul></td></tr><tr><td><p><strong>A12</strong></p></td><td><p><strong>Statistical Power</strong></p><p><strong>[NEW ITEM]</strong></p></td><td><p>Is statistical power assessed or sample size adequately justified for detecting clinically relevant effects?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li><strong>Formal power calculation: </strong>Statistical power calculated using R¬≤ and sample sizes</li><li><strong>Minimum detectable effect size:</strong> Calculated and reported (e.g., ‚Äú80% power to detect OR &gt; 1.15‚Äù)</li><li><strong>Sample size justification:</strong> Discussion of adequacy relative to expected effect sizes</li><li><strong>Power calculation software/formula referenced: </strong>mRnd, Mendelian randomization power calculator, or formula citation</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No power assessment</li><li>Only general statements about ‚Äúlarge sample sizes‚Äù</li></ul></td></tr></tbody></table>\n",
    "\n",
    "#### Additional Quality Indicators\n",
    "\n",
    "**Critical Items for Study Validity** (Must score 1 for minimum quality):\n",
    "\n",
    "- A1 (Data Sources)\n",
    "- A2 (Instrument Selection)\n",
    "- A3 (Instrument Strength - must not score -1)\n",
    "- A9 (Outlier Detection)\n",
    "- A10 (Sensitivity Analyses)\n",
    "\n",
    "**Methodological Rigor Indicators** (Items that distinguish high-quality studies):\n",
    "\n",
    "- A4 (MR Assumptions empirical testing)\n",
    "- A11 (Multiple robust estimators)\n",
    "- A12 (Statistical power assessment)\n",
    "\n",
    "#### Overall Part A Quality Assessment\n",
    "\n",
    "**High Quality Core Methods:** ‚â•85% of applicable items scored ‚â•1, with all critical items = 1\n",
    "\n",
    "**Moderate Quality:** 70-84% of applicable items scored ‚â•1\n",
    "\n",
    "**Low Quality:** <70% of applicable items scored ‚â•1 OR any critical item = 0\n",
    "\n",
    "### Part B: Cross-Ancestry Extensions to MR Methodology\n",
    "\n",
    "**Scoring Instructions**:\n",
    "\n",
    "- **0 = Not Addressed**: Item missing or not discussed anywhere in paper\n",
    "- **1 = Fully Addressed**: Item explicitly addressed with required elements present\n",
    "- **N/A**: Item clearly not applicable to study design\n",
    "- **Specific numeric thresholds and keywords are provided below to minimize reviewer interpretation**\n",
    "\n",
    "<table><tbody><tr><th><p><strong>Item</strong></p></th><th><p><strong>Category</strong></p></th><th><p><strong>Question</strong></p></th><th><p><strong>Evaluation Criteria</strong></p></th></tr><tr><td><p><strong>B1</strong></p></td><td><p><strong>Ancestry Reporting</strong></p></td><td><p>Are ancestries of Exposure and Outcome GWAS explicitly reported with sample composition details?</p></td><td><p><strong>Score 1 if ALL of the following are present:</strong></p><ul><li>Ancestry of exposure GWAS explicitly stated using standard terms (European, East Asian, African, South Asian, Hispanic/Latino, Native American, Oceanian, or specific population names)</li><li>Ancestry of outcome GWAS explicitly stated using same terminology</li><li>For multi-ancestry GWAS: numerical breakdown provided (e.g., \"80% European, 15% East Asian, 5% African\" OR sample sizes per ancestry group)</li><li>For admixed populations: either ancestry proportions OR population-specific labels (e.g., \"African American,\" \"Hispanic/Latino\")</li></ul><p><strong>Score 0 if ANY of the following:</strong></p><ul><li>Ancestry described only as \"diverse,\" \"mixed,\" or \"multi-ethnic\" without specifics</li><li>Missing ancestry information for either exposure or outcome GWAS</li><li>Multi-ancestry GWAS mentioned without numerical breakdown</li></ul></td></tr><tr><td><p><strong>B2</strong></p></td><td><p><strong>Cross-Ancestry Harmonization</strong></p></td><td><p>Are exposure and outcome GWAS ancestry-matched, or is ancestry mismatch explicitly tested?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li>Both exposure and outcome GWAS use identical ancestry populations (e.g., both European-only)</li><li>Cross-ancestry analysis with explicit testing: stratified analysis by ancestry reported</li><li>Replication performed in matched ancestry groups</li><li>Formal heterogeneity testing across ancestry groups with results discussed</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Exposure and outcome GWAS use different ancestries without any testing or justification</li><li>Authors acknowledge mismatch but provide no empirical evaluation</li></ul></td></tr><tr><td><p><strong>B3</strong></p></td><td><p><strong>LD Structure Compatibility</strong></p></td><td><p>Is ancestry-appropriate LD reference panel used for instrument selection and pruning?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>LD reference panel explicitly named (e.g., \"1000 Genomes Phase 3 EUR,\" \"gnomAD v3.1 EAS\")</li><li>Reference panel ancestry matches GWAS ancestry for instrument selection</li><li>LD pruning parameters stated (r¬≤ threshold, window size)</li><li>For multi-ancestry: either ancestry-specific panels used OR justification for single panel provided</li></ul><p><strong>Score 0 if ANY missing:</strong></p><ul><li>LD reference panel not named</li><li>Clear ancestry mismatch between panel and GWAS</li><li>LD parameters not specified</li></ul></td></tr><tr><td><p><strong>B4</strong></p></td><td><p><strong>Ancestry-Specific Instrument Strength</strong></p></td><td><p>Is instrument strength evaluated separately for each ancestry group?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>F-statistics OR R¬≤ reported separately for each ancestry in exposure GWAS</li><li>For single-ancestry exposure with multi-ancestry outcome: strength metrics calculated using ancestry-matched exposure data</li><li>Weak instrument bias discussed in context of ancestry-specific effects</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only pooled/overall instrument strength reported</li><li>Ancestry-specific strength not evaluated despite multi-ancestry data</li></ul></td></tr><tr><td><p><strong>B5</strong></p></td><td><p><strong>Allele Frequency Validation</strong></p></td><td><p>Are minor allele frequencies (MAF) reported and appropriate thresholds applied per ancestry?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>MAF thresholds explicitly stated (e.g., \"MAF &gt; 0.01,\" \"MAF &gt; 0.05\")</li><li>MAF filtering applied separately by ancestry OR ancestry-specific MAF values reported</li><li>Number of SNPs excluded due to low MAF reported by ancestry group (if applicable)</li></ul><p><strong>Score 0 if:</strong></p><ul><li>MAF thresholds not specified</li><li>Only pooled MAF filtering without ancestry consideration</li><li>MAF information completely absent</li></ul></td></tr><tr><td><p><strong>B6</strong></p></td><td><p><strong>Instrument Transferability</strong></p></td><td><p>Is the validity of applying genetic instruments across ancestries explicitly justified?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following:</strong></p><ul><li><strong>Empirical replication:</strong> MR analysis replicated in target ancestry with results compared</li><li><strong>LD/frequency comparison:</strong> Explicit comparison of instrument LD patterns or allele frequencies across ancestries with data shown</li><li><strong>Biological justification:</strong> Stated rationale for cross-ancestry generalizability referencing conserved biological pathways, gene function, or mechanistic studies</li><li><strong>Literature support: </strong>Citations to studies demonstrating cross-ancestry validity of specific instruments used</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No justification provided for cross-ancestry instrument application</li><li>Only general statements about genetic similarity without specific evidence</li><li>Transferability assumed without discussion</li></ul></td></tr><tr><td><p><strong>B7</strong></p></td><td><p><strong>Phenotype Consistency</strong></p></td><td><p>Are exposure and outcome phenotypes defined consistently across ancestry groups?</p></td><td><p><strong>Score 1 if ALL applicable elements present:</strong></p><p><strong><em>For binary traits:</em></strong></p><ul><li>Identical diagnostic criteria across ancestries (e.g., same ICD codes, clinical thresholds)</li><li>Case/control definitions explicitly stated for each ancestry</li></ul><p><strong><em>For continuous traits:</em></strong></p><ul><li>Measurement units consistent across ancestries (e.g., all BMI in kg/m¬≤)</li><li>Standardization methods described if units differ</li><li>Transformation procedures (log, inverse-normal) applied consistently</li></ul><p><strong>Score 0 if ANY of the following:</strong></p><ul><li>Different diagnostic criteria used across ancestries without harmonization</li><li>Measurement units inconsistent without conversion</li><li>Phenotype definitions not specified for one or more ancestry groups</li></ul></td></tr><tr><td><p><strong>B8</strong></p></td><td><p><strong>Ancestry-Stratified Analysis</strong></p></td><td><p>Are MR results reported by ancestry and/or tested for heterogeneity across ancestry groups?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following:</strong></p><ul><li>Stratified results: MR estimates reported separately for each ancestry with effect sizes and confidence intervals</li><li>Formal heterogeneity testing: Cochran's Q, I¬≤, or similar tests performed across ancestries with p-values and interpretation</li><li>Meta-analysis approach: Random/fixed effects meta-analysis across ancestry groups with heterogeneity assessment</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only pooled results reported without ancestry breakdown</li><li>Heterogeneity mentioned but not formally tested</li><li>Results combined across ancestries without consideration of differences</li></ul></td></tr><tr><td><p><strong>B9</strong></p></td><td><p><strong>Colocalization Analysis</strong></p></td><td><p>Is colocalization or fine-mapping used to assess whether instruments tag the same causal variants across ancestries?</p></td><td><p><strong>Score 1 if ANY of the following methods applied:</strong></p><ul><li><strong>Formal colocalization:</strong> COLOC, eCAVIAR, or similar methods with posterior probabilities reported</li><li><strong>Fine-mapping comparison:</strong> SuSiE, FINEMAP, or credible sets compared across ancestries</li><li><strong>Lead SNP analysis:</strong> Assessment of whether lead SNPs are identical or in high LD (r¬≤ &gt; 0.8) across ancestries</li><li><strong>Conditional analysis:</strong> Testing whether signals remain after conditioning on lead variants</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No assessment of variant-level concordance across ancestries</li><li>Only mentions colocalization without formal analysis</li></ul></td></tr><tr><td><p><strong>B10</strong></p></td><td><p><strong>Ancestry-Specific Pleiotropy</strong></p></td><td><p>Does the study evaluate whether SNP-outcome associations differ across ancestries independently of the exposure?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following:</strong></p><ul><li>Ancestry-stratified pleiotropy tests: MR-Egger intercepts, MR-PRESSO, or radial MR performed separately by ancestry with results compared</li><li>Confounder testing by ancestry: Instruments tested for association with known confounders in each ancestry group separately</li><li>Pathway analysis: Discussion of ancestry-specific biological pathways or gene expression differences that could affect pleiotropy</li><li>Negative control analysis: Testing instruments against negative control outcomes in each ancestry</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only pooled pleiotropy testing without ancestry stratification</li><li>Pleiotropy discussed generally without ancestry-specific evaluation</li></ul></td></tr><tr><td><p><strong>B11</strong></p></td><td><p><strong>Population Stratification</strong></p><p><strong>[NEW ITEM]</strong></p></td><td><p>Are population stratification and cryptic relatedness adequately controlled within and across ancestry groups?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>Principal components (PCs) inclusion explicitly stated with number of PCs reported</li><li>Genomic control (Œª) values reported and appropriate (Œª &lt; 1.1 preferred, Œª &lt; 1.2 acceptable)</li><li>For multi-ancestry analysis: either ancestry-specific PC calculation OR justified approach for combined analysis</li><li>Relatedness filtering described (e.g., IBD &lt; 0.05, kinship thresholds)</li></ul><p><strong>Score 0 if ANY missing:</strong></p><ul><li>PC adjustment not mentioned</li><li>Genomic control not reported or Œª &gt; 1.2</li><li>No relatedness filtering described</li></ul></td></tr><tr><td><p><strong>B12</strong></p></td><td><p><strong>Effect Size Interpretation</strong></p><p><strong>[NEW ITEM]</strong></p></td><td><p>Are effect sizes interpreted appropriately considering ancestry-specific baseline risks and phenotype distributions?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>Authors acknowledge potential differences in baseline risk/phenotype distributions across ancestries</li><li>Effect sizes discussed in context of ancestry-specific clinical relevance</li><li>Absolute risk differences calculated or discussed where appropriate</li><li>Limitations regarding generalizability of effect sizes across populations mentioned</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Effect sizes interpreted identically across ancestries without consideration of population differences</li><li>No discussion of clinical relevance by ancestry</li></ul></td></tr></tbody></table>\n",
    "\n",
    "#### Additional Scoring Guidelines\n",
    "\n",
    "**For Multi-Ancestry Studies:** All items in Part B are applicable\n",
    "\n",
    "**For Cross-Ancestry Studies (exposure and outcome from different ancestries):** Items B2, B6, B7, B10, B12 are particularly critical\n",
    "\n",
    "**For Single-Ancestry Studies with Multi-Ancestry GWAS:** Items B1, B3, B4, B5, B11 apply\n",
    "\n",
    "#### Quality Thresholds for Overall Assessment\n",
    "\n",
    "**High Quality Cross-Ancestry Methods:** ‚â•80% of applicable Part B items scored as 1\n",
    "\n",
    "**Moderate Quality:** 60-79% of applicable Part B items scored as 1\n",
    "\n",
    "**Low Quality:** <60% of applicable Part B items scored as 1\"\"\"\n",
    "\n",
    "\n",
    "import os\n",
    "import time\n",
    "import json\n",
    "import openai\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from secret import OPENAI_API_KEY\n",
    "\n",
    "import regex  # instead of re\n",
    "\n",
    "def extract_json_objects(text):\n",
    "    # Try to load full string as a list of dicts\n",
    "    try:\n",
    "        data = json.loads(text)\n",
    "        if isinstance(data, list):\n",
    "            return data[0]\n",
    "        else:\n",
    "            return data\n",
    "    except json.JSONDecodeError:\n",
    "        print(\"Response:\")  # Print first 100 chars for debugging\n",
    "        print(text)\n",
    "        pass  # Try regex fallback below\n",
    "\n",
    "    # Fallback regex in case it's not clean JSON\n",
    "\n",
    "\n",
    "    pattern = r\"\\{(?:[^{}]|(?R))*\\}\"  # recursively match nested {}\n",
    "    matches = regex.findall(pattern, text)\n",
    "\n",
    "    objects = []\n",
    "    for m in matches:\n",
    "        try:\n",
    "            obj = json.loads(m)\n",
    "            objects.append(obj)\n",
    "        except json.JSONDecodeError:\n",
    "            continue\n",
    "\n",
    "    return objects[0]\n",
    "\n",
    "\n",
    "# Set your OpenAI API key\n",
    "openai.api_key = OPENAI_API_KEY  # Ensure this environment variable is set\n",
    "\n",
    "# Paths\n",
    "pdf_dir = \"./documents\"\n",
    "output_csv = \"chatgpt_new_extracted_mr_data.csv\"\n",
    "\n",
    "from templates.rubric import rubric_prompt\n",
    "\n",
    "# Initialize OpenAI client\n",
    "client = openai.OpenAI(\n",
    "    api_key=openai.api_key,\n",
    ")\n",
    "\n",
    "# Create an assistant with file search capability\n",
    "assistant = client.beta.assistants.create(\n",
    "    name=\"MR Study Extractor\",\n",
    "    instructions=rubric_prompt,\n",
    "    model=\"gpt-4-turbo\",\n",
    "    tools=[{\"type\": \"file_search\"}],\n",
    ")\n",
    "\n",
    "RESPONSE_DIR = \"./responses\"\n",
    "os.makedirs(RESPONSE_DIR, exist_ok=True)\n",
    "\n",
    "class GlobalDebug:\n",
    "    pass\n",
    "\n",
    "def process_pdf(file_path, index):\n",
    "    file_name = os.path.basename(file_path)\n",
    "    print(f\"\\nüîç Processing [{index}] {file_name}\")\n",
    "\n",
    "    # Upload the PDF\n",
    "    try:\n",
    "        with open(file_path, \"rb\") as f:\n",
    "            uploaded_file = client.files.create(file=f, purpose=\"assistants\")\n",
    "    except Exception as e:\n",
    "        print(f\"[ERROR][{index}] Failed to upload file {file_name}:\\n{e}\")\n",
    "        return None\n",
    "\n",
    "    # Create a thread\n",
    "    try:\n",
    "        thread = client.beta.threads.create()\n",
    "    except Exception as e:\n",
    "        print(f\"[ERROR][{index}] Failed to create thread for {file_name}:\\n{e}\")\n",
    "        return None\n",
    "\n",
    "    # Helper to run one prompt and log output\n",
    "    def run_prompt(prompt, label):\n",
    "        # try:\n",
    "        client.beta.threads.messages.create(\n",
    "            thread_id=thread.id,\n",
    "            role=\"user\",\n",
    "            content=prompt,\n",
    "            attachments=[{\"file_id\": uploaded_file.id, \"tools\": [{\"type\": \"file_search\"}]}],\n",
    "        )\n",
    "\n",
    "        run = client.beta.threads.runs.create(\n",
    "            thread_id=thread.id,\n",
    "            assistant_id=assistant.id,\n",
    "        )\n",
    "\n",
    "        while True:\n",
    "            run_status = client.beta.threads.runs.retrieve(thread_id=thread.id, run_id=run.id)\n",
    "\n",
    "            GlobalDebug.run_status = run_status  # Store for debugging\n",
    "            GlobalDebug.thread_id = thread.id  # Store for debugging\n",
    "            GlobalDebug.run_id = run.id  # Store for debugging\n",
    "            \n",
    "            if run_status.status == \"completed\":\n",
    "                break\n",
    "            elif run_status.status == \"failed\":\n",
    "                print(f\"Status info: {run_status}\")\n",
    "                raise RuntimeError(f\"Run failed on {label}\")\n",
    "            time.sleep(1)\n",
    "\n",
    "        messages = client.beta.threads.messages.list(thread_id=thread.id)\n",
    "        response_text = messages.data[0].content[0].text.value\n",
    "\n",
    "        # Save raw response\n",
    "        raw_path = os.path.join(RESPONSE_DIR, f\"{index:03d}_{file_name}_{label}.txt\")\n",
    "        with open(raw_path, \"w\", encoding=\"utf-8\") as f:\n",
    "            f.write(response_text)\n",
    "\n",
    "        print(response_text)\n",
    "        \n",
    "        return extract_json_objects(response_text)\n",
    "\n",
    "        # except Exception as e:\n",
    "        #     print(f\"[ERROR][{index}] Failed during '{label}' for {file_name}:\\n{e}\")\n",
    "        #     return None\n",
    "\n",
    "    # Run both prompts and combine results\n",
    "    data1 = run_prompt(rubric_prompt_1, \"part1\")\n",
    "    data2 = run_prompt(rubric_prompt_2, \"part2\")\n",
    "\n",
    "    if not data1 or not data2:\n",
    "        print(f\"[SKIP][{index}] Skipping {file_name} due to failed prompt(s).\")\n",
    "        return None\n",
    "\n",
    "    combined = {\n",
    "        \"study_id\": file_name,\n",
    "        **data1,\n",
    "        **data2\n",
    "    }\n",
    "    return combined\n",
    "\n",
    "# Process all PDFs in the directory\n",
    "results = []\n",
    "pdf_files = sorted([f for f in os.listdir(pdf_dir) if f.endswith(\".pdf\")])\n",
    "\n",
    "for i, pdf_file in enumerate(tqdm(pdf_files, desc=\"Processing PDFs\"), 1):\n",
    "    pdf_path = os.path.join(pdf_dir, pdf_file)\n",
    "    result = process_pdf(pdf_path, i)\n",
    "    if result:\n",
    "        results.append(result)\n",
    "\n",
    "# Save results to CSV\n",
    "if results:\n",
    "    df = pd.DataFrame(results)\n",
    "    df.to_csv(output_csv, index=False)\n",
    "    print(f\"\\n‚úÖ Saved extracted data to: {output_csv}\")\n",
    "else:\n",
    "    print(\"\\n‚ö†Ô∏è No data extracted.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "b7575acc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'id': 'run_RelPqwpVYIoRN5Y5G8bgBPlw',\n",
       " 'assistant_id': 'asst_lv3278Ccd2N2HL5s1WnKGP7W',\n",
       " 'cancelled_at': None,\n",
       " 'completed_at': None,\n",
       " 'created_at': 1751503380,\n",
       " 'expires_at': None,\n",
       " 'failed_at': 1751503387,\n",
       " 'incomplete_details': None,\n",
       " 'instructions': 'I am conducting a Methods Audit of Mendelian Randomization (MR) studies using a study characteristics form and a structured scoring rubric. I will upload the MR study as a PDF file.\\n\\nPlease do the following:\\n\\n**1\\\\. Use the attached study characteristics form to extract the relevant data from the MR study.**\\n\\n**2\\\\. Use the attached rubric (Parts A and B) to score the MR study.**\\n\\n- Score each item as 0, 1, or N/A based on the rubric\\'s detailed evaluation criteria.\\n\\n**3\\\\. Output Format (JSON)**\\n\\nReturn only a single structured JSON object with the following three components.\\nDo not include any explanations, notes, or additional text.\\n\\n1. **characteristics  \\n    Contains extracted responses for each item in the Study Characteristics Form (Q1‚ÄìQ20).**\\n2. **scoring  \\n    Includes scores for each rubric item in Part A (A1‚ÄìA12) and Part B (B1‚ÄìB12), using 0, 1, or \"N/A\".**\\n3. **evidence  \\n    For each item in A1‚ÄìA12 and B1‚ÄìB12, include:**\\n    - **score: the assigned value (0, 1, or \"N/A\")**\\n    - **quote: verbatim excerpt from the paper**\\n    - **section: the section where the quote was found (e.g., \"Methods\", \"Results\")**\\n\\n**Use the PDF file name as the value for study_id.**\\n\\n**Example Output Format**\\n\\n```json\\n{\\n  \"study_id\": \"Chen2022.pdf\",\\n  \"characteristics\": {\\n    \"Q1\": \"...\",\\n    \"Q2\": \"...\",\\n    \"Q3\": \"...\",\\n    \"...\": \"...\",\\n    \"Q20\": \"...\"\\n  },\\n  \"scoring\": {\\n    \"A\": {\\n      \"A1\": 1,\\n      \"A2\": 0,\\n      \"...\": \"N/A\"\\n    },\\n    \"B\": {\\n      \"B1\": 1,\\n      \"B2\": 0,\\n      \"...\": \"N/A\"\\n    }\\n  },\\n  \"evidence\": {\\n    \"A\": {\\n      \"A1\": {\\n        \"score\": 1,\\n        \"quote\": \"...verbatim text from paper...\",\\n        \"section\": \"Methods ‚Äì Instrument Selection\"\\n      },\\n      \"A2\": {\\n        \"score\": 0,\\n        \"quote\": \"N/A\",\\n        \"section\": \"N/A\"\\n      }\\n    },\\n    \"B\": {\\n      \"B1\": {\\n        \"score\": 1,\\n        \"quote\": \"...\",\\n        \"section\": \"Results ‚Äì Sample Characteristics\"\\n      }\\n    }\\n  }\\n}\\n```\\n\\n**Notes:**\\n\\n- Follow the rubric‚Äôs critical item and quality threshold rules if applicable.\\n- If any item is unclear or cannot be determined from the study, mark it as N/A and briefly explain why.\\n\\n# Study Characteristics Form\\n\\n| **Label** | **Field** | **Question** |\\n| --- | --- | --- |\\n| Q1  | Study ID | What is the study‚Äôs citation shorthand (first author and publication year, e.g. Storm 2023)? |\\n| Q2  | Study Title | What is the full title of the article? |\\n| Q3  | Journal | What is the full name of the journal in which the article was published? |\\n| Q4  | Publication Year | In what year was the article published? |\\n| Q5  | Study Design / MR Type | What type(s) of MR design(s) were used? (e.g. One-sample MR, Two-sample MR, Multivariable MR, Bidirectional MR, or combinations) |\\n| Q6  | Instrumental Variable(s) | What types of genetic instruments were used (e.g. GWAS SNPs, cis-variants, PRS)? If SNPs were LD-clumped, what were the clumping parameters (e.g. r¬≤ threshold, physical distance window)? |\\n| Q7  | Number of SNPs per Exposure | How many SNPs were used for each exposure? Report counts separately for each exposure and ancestry group.<br><br>Example: BMI: 62 SNPs (EAS), 298 SNPs (EUR); CRP: 6 SNPs (EAS), 183 SNPs (EUR); HDL-C: 50 SNPs (EAS), 247 SNPs (EUR); BS: 15 SNPs (EAS), 93 SNPs (EUR); TGs: 36 SNPs (EAS), 204 SNPs (EUR); SBP: 22 SNPs (EAS), 158 SNPs (EUR) |\\n| Q8  | Exposure(s) | What traits, biomarkers, or risk factors were analyzed as exposures? |\\n| Q9  | Outcome(s) | What traits, diseases, or phenotypes were analyzed as outcomes? |\\n| Q10 | Number of Exposures Assessed | How many distinct exposures were included? |\\n| Q11 | Number of Outcomes Assessed | How many distinct outcomes were assessed? |\\n| Q12 | GWAS Source for Exposure(s) | What GWAS datasets or consortia provided SNP‚Äìexposure associations? List all.<br><br>Example: ALT/AST: UK Biobank (Neale Lab); NAFLD liability: Million Veteran Program; liver MRI: UK Biobank subset; East Asian: Biobank Japan |\\n| Q13 | GWAS Source for Outcome(s) | What GWAS datasets or consortia provided SNP‚Äìoutcome associations? List all.<br><br>Example: CAD: CARDIoGRAM; stroke: MEGASTROKE; atrial fibrillation: published GWAS; heart failure: HERMES consortium; T2D: DIAMANTE consortium; glycaemic traits: MAGIC; East Asian: Biobank Japan, AGEN consortium |\\n| Q14 | Sample Size for Exposure(s) | What was the total sample size for each exposure dataset, including cases and controls if applicable? |\\n| Q15 | Sample Size for Outcome(s) | What was the total sample size for each outcome dataset, including cases and controls if applicable? |\\n| Q16 | Ancestries Represented in Exposure GWAS | What ancestry groups were included in the exposure GWAS (e.g. European, East Asian)? |\\n| Q17 | Ancestries Represented in Outcome GWAS | What ancestry groups were included in the outcome GWAS? |\\n| Q18 | Separate MR Analyses by Ancestry | Did the study conduct ancestry-stratified MR analyses? (Yes/No) |\\n| Q19 | Geographic Region(s) Represented | What geographic regions or countries were the study populations drawn from |\\n| Q20 | Software Used | What statistical software, packages, or MR tools were used (e.g. R, Stata, TwoSampleMR, MR-Base, GSMR, LDSC)? |\\n\\n# Scoring Rubric\\n\\n### Part A: Core MR Methodology\\n\\n**Scoring Instructions**:\\n\\n- **0 = Not Addressed**: Item missing or not discussed anywhere in paper\\n- **1 = Fully Addressed**: Item explicitly addressed with required elements present\\n- **N/A**: Item clearly not applicable to study design\\n- **Specific numeric thresholds and keywords are provided below to minimize reviewer interpretation**\\n\\n<table><tbody><tr><th><p><strong>Item</strong></p></th><th><p><strong>Category</strong></p></th><th><p><strong>Question</strong></p></th><th><p><strong>Evaluation Criteria</strong></p></th></tr><tr><td><p><strong>A1</strong></p></td><td><p><strong>Data Sources</strong></p></td><td><p>Are Exposure and Outcome GWAS described with source, ancestry, and sample size?</p></td><td><p><strong>Score 1 if ALL of the following for BOTH exposure and outcome GWAS:</strong></p><ul><li>Source identification: Study name (e.g., ‚ÄúUK Biobank‚Äù), consortium (e.g., ‚ÄúGIANT‚Äù), or specific cohort clearly stated</li><li>Sample size: Total N provided as specific number (not ranges like ‚Äú~500,000‚Äù)</li><li>Ancestry composition: Population ancestry explicitly stated using standard terms or percentages</li></ul><p><strong>Score 0 if ANY element missing or vague:</strong></p><ul><li>Source described only as ‚Äúpublished GWAS‚Äù or ‚Äúlarge-scale study‚Äù</li><li>Sample size missing, unclear, or given as approximation</li><li>Ancestry not specified or described only as ‚Äúmixed‚Äù without detail</li></ul></td></tr><tr><td><p><strong>A2</strong></p></td><td><p><strong>Instrument Selection</strong></p></td><td><p>Are SNP instruments selected using genome-wide significance and LD pruning/clumping with parameters specified?</p></td><td><p><strong>Score 1 if ALL of the following criteria present:</strong></p><ul><li>Genome-wide significance: p &lt; 5√ó10‚Åª‚Å∏ threshold explicitly stated</li><li>LD pruning/clumping: Method clearly specified (pruning OR clumping)</li><li>LD parameters: r¬≤ threshold stated (e.g., r¬≤ &lt; 0.001, r¬≤ &lt; 0.01)</li><li>Distance parameter: Window size specified (e.g., 1MB, 250kb, 10,000kb)</li><li>Reference panel: LD reference panel named (e.g., ‚Äú1000 Genomes Phase 3‚Äù)</li></ul><p><strong>Score 0 if ANY of the following:</strong></p><ul><li>Different p-value threshold used (e.g., p &lt; 5√ó10‚Åª‚Å∂) without justification</li><li>LD method not specified (‚Äúindependent SNPs‚Äù without method)</li><li>Parameters missing (r¬≤ or distance threshold not provided)</li><li>Reference panel not identified</li></ul></td></tr><tr><td><p><strong>A3a</strong></p></td><td><p><strong>Instrument Strength - Reporting</strong></p></td><td><p>Is instrument strength reported using F-statistics or R¬≤?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li>F-statistics provided with values (per instrument OR mean F-statistic)</li><li>R¬≤ (variance explained) provided as percentage or proportion</li><li>Both F-statistics and R¬≤ reported</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Strength mentioned but no values provided (e.g., ‚Äústrong instruments‚Äù)</li><li>Only weak instrument bias mentioned without metrics</li><li>No mention of instrument strength</li></ul></td></tr><tr><td><p><strong>A3b</strong></p></td><td><p><strong>Instrument Strength - Adequacy</strong></p></td><td><p>If F-statistics reported, are they adequate (F ‚â• 10)?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>F ‚â• 10</li></ul><p><strong>Score 0 if:</strong></p><ul><li>F &lt; 10</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>F-statistics not reported</li></ul></td></tr><tr><td><p><strong>A4</strong></p></td><td><p><strong>MR Assumptions</strong></p></td><td><p>Are the three core IV assumptions explicitly stated and at least one empirically evaluated?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li><strong>All three assumptions named: </strong>Relevance (instrument-exposure association), Independence (no confounding), Exclusion restriction (no pleiotropy)</li><li><strong>At least one assumption empirically tested</strong> using ANY of:</li><li>Confounder association testing (PhenoScanner, manual curation)</li><li>Known confounder control testing</li><li>Pleiotropy detection methods (MR-Egger, MR-PRESSO)</li><li>Negative control analyses</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Assumptions mentioned but not all three clearly identified</li><li>No empirical evaluation of any assumption</li><li>Only theoretical discussion without testing</li></ul></td></tr><tr><td><p><strong>A5</strong></p></td><td><p><strong>Harmonization</strong></p></td><td><p>Are effect alleles harmonized and strand alignment issues addressed between datasets?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following approaches clearly described:</strong></p><ul><li><strong>Automated harmonization: </strong>Use of harmonization functions/packages (e.g., TwoSampleMR harmonise_data(), MungeSumstats)</li><li><strong>Manual harmonization: </strong>Process for aligning effect alleles described with specific steps</li><li><strong>Strand flip handling:</strong> Explicit mention of identifying and correcting strand flips</li><li><strong>Ambiguous SNP removal: </strong>A/T and G/C SNPs excluded or handled with frequency-based inference</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No mention of harmonization procedures</li><li>Only states ‚Äúdata were harmonized‚Äù without method description</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>Single-sample MR study</li></ul></td></tr><tr><td><p><strong>A6</strong></p></td><td><p><strong>Palindromic SNPs</strong></p></td><td><p>Are palindromic (A/T, G/C) SNPs handled appropriately?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li><strong>Exclusion approach:</strong> A/T and G/C SNPs explicitly excluded</li><li><strong>Frequency-based inference:</strong> Allele frequencies used to determine strand alignment with frequency threshold stated (e.g., MAF &lt; 0.42 or 0.45)</li><li><strong>Reference-based alignment: </strong>Use of reference panel allele frequencies for alignment</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Palindromic SNPs not mentioned</li><li>Handled but method not specified</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>Single-sample MR study</li></ul></td></tr><tr><td><p><strong>A7</strong></p></td><td><p><strong>Sample Overlap</strong></p></td><td><p>Is sample overlap between exposure and outcome GWAS appropriately addressed?</p></td><td><p><strong>For 2-sample MR - Score 1 if:</strong></p><ul><li>Sample overlap explicitly discussed (even if stated as ‚Äúnone‚Äù or ‚Äúminimal‚Äù)</li><li>Overlap quantified when present (e.g., ‚Äú15% overlap‚Äù)</li><li>Appropriate methods used when overlap exists (e.g., CAUSE, MR-RAPS adjustment)</li></ul><p><strong>For 1-sample MR - Score 1 if:</strong></p><ul><li>Two-stage least squares (2SLS) or equivalent method used</li><li>Appropriate software mentioned (e.g., ivreg, ivpack)</li><li>Method justification provided for using same sample</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Sample overlap not mentioned in 2-sample MR</li><li>1-sample MR without appropriate statistical method</li></ul></td></tr><tr><td><p><strong>A8</strong></p></td><td><p><strong>Confounder Control</strong></p></td><td><p>Are limitations of confounder control acknowledged (2-sample) or covariates appropriately controlled (1-sample)?</p></td><td><p><strong>For 2-sample MR - Score 1 if:</strong></p><ul><li>Explicit acknowledgment that individual-level covariates cannot be controlled</li><li>Discussion of residual confounding as study limitation</li><li>Population stratification control mentioned (if applicable)</li></ul><p><strong>For 1-sample MR - Score 1 if:</strong></p><ul><li>Covariate adjustment clearly described</li><li>Standard covariates included: age, sex, principal components</li><li>Method for covariate selection described</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No discussion of confounder control limitations (2-sample)</li><li>No covariate adjustment described (1-sample)</li></ul></td></tr><tr><td><p><strong>A9</strong></p></td><td><p><strong>Outlier Detection</strong></p></td><td><p>Are outlier instruments identified using systematic methods and sensitivity analysis performed?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>Outlier detection method applied: Any systematic approach (leave-one-out analysis, radial MR, Cook\\'s distance, MVMR-cML)</li><li>Method clearly named: Specific technique identified, not just ‚Äúoutlier analysis‚Äù</li><li>Sensitivity analysis: Results presented both with and without identified outliers</li><li>Impact discussed: Effect of outlier removal on estimates reported</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No systematic outlier detection</li><li>Method not specified</li><li>No sensitivity analysis performed</li></ul></td></tr><tr><td><p><strong>A10</strong></p></td><td><p><strong>Sensitivity Analyses</strong></p></td><td><p>Are pleiotropy or heterogeneity assessed using appropriate statistical tests?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following methods applied with results reported:&lt;br/&gt;‚Ä¢</strong></p><ul><li>MR-Egger regression: Intercept and slope reported with p-values</li><li>Weighted median: Estimates and confidence intervals provided</li><li>MR-PRESSO: Global test and outlier correction results</li><li>Heterogeneity tests: Cochran\\'s Q test with p-value and I¬≤ statistic</li><li>Radial MR: Modified Q-statistic and outlier identification</li><li>Contamination mixture methods: MR-Mix, CAUSE, or similar</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Methods mentioned but results not provided</li><li>Only theoretical discussion of pleiotropy</li><li>No statistical testing performed</li></ul></td></tr><tr><td><p><strong>A11a</strong></p></td><td><p><strong>Robust Estimators - Use</strong></p></td><td><p>Are alternative estimators beyond inverse-variance weighted (IVW) used?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>At least one additional estimator beyond IVW used from: Weighted median, Weighted mode, MR-Egger, MR-RAPS, GSMR, or other validated methods</li><li>Results for additional estimators reported with confidence intervals</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only IVW method used</li><li>Additional methods mentioned but results not reported</li></ul></td></tr><tr><td><p><strong>A11b</strong></p></td><td><p><strong>Robust Estimators - Results</strong></p></td><td><p>Are results consistent across multiple estimators?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>Multiple estimators used AND results consistent across methods with explicit comparison</li><li>Discordant results appropriately discussed with potential explanations</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Results are inconsistent</li><li>Results are not compared</li></ul><p><strong>Mark N/A if:</strong></p><ul><li>Only one estimator used</li></ul></td></tr><tr><td><p><strong>A12</strong></p></td><td><p><strong>Statistical Power</strong></p><p><strong>[NEW ITEM]</strong></p></td><td><p>Is statistical power assessed or sample size adequately justified for detecting clinically relevant effects?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li><strong>Formal power calculation: </strong>Statistical power calculated using R¬≤ and sample sizes</li><li><strong>Minimum detectable effect size:</strong> Calculated and reported (e.g., ‚Äú80% power to detect OR &gt; 1.15‚Äù)</li><li><strong>Sample size justification:</strong> Discussion of adequacy relative to expected effect sizes</li><li><strong>Power calculation software/formula referenced: </strong>mRnd, Mendelian randomization power calculator, or formula citation</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No power assessment</li><li>Only general statements about ‚Äúlarge sample sizes‚Äù</li></ul></td></tr></tbody></table>\\n\\n#### Additional Quality Indicators\\n\\n**Critical Items for Study Validity** (Must score 1 for minimum quality):\\n\\n- A1 (Data Sources)\\n- A2 (Instrument Selection)\\n- A3 (Instrument Strength - must not score -1)\\n- A9 (Outlier Detection)\\n- A10 (Sensitivity Analyses)\\n\\n**Methodological Rigor Indicators** (Items that distinguish high-quality studies):\\n\\n- A4 (MR Assumptions empirical testing)\\n- A11 (Multiple robust estimators)\\n- A12 (Statistical power assessment)\\n\\n#### Overall Part A Quality Assessment\\n\\n**High Quality Core Methods:** ‚â•85% of applicable items scored ‚â•1, with all critical items = 1\\n\\n**Moderate Quality:** 70-84% of applicable items scored ‚â•1\\n\\n**Low Quality:** <70% of applicable items scored ‚â•1 OR any critical item = 0\\n\\n### Part B: Cross-Ancestry Extensions to MR Methodology\\n\\n**Scoring Instructions**:\\n\\n- **0 = Not Addressed**: Item missing or not discussed anywhere in paper\\n- **1 = Fully Addressed**: Item explicitly addressed with required elements present\\n- **N/A**: Item clearly not applicable to study design\\n- **Specific numeric thresholds and keywords are provided below to minimize reviewer interpretation**\\n\\n<table><tbody><tr><th><p><strong>Item</strong></p></th><th><p><strong>Category</strong></p></th><th><p><strong>Question</strong></p></th><th><p><strong>Evaluation Criteria</strong></p></th></tr><tr><td><p><strong>B1</strong></p></td><td><p><strong>Ancestry Reporting</strong></p></td><td><p>Are ancestries of Exposure and Outcome GWAS explicitly reported with sample composition details?</p></td><td><p><strong>Score 1 if ALL of the following are present:</strong></p><ul><li>Ancestry of exposure GWAS explicitly stated using standard terms (European, East Asian, African, South Asian, Hispanic/Latino, Native American, Oceanian, or specific population names)</li><li>Ancestry of outcome GWAS explicitly stated using same terminology</li><li>For multi-ancestry GWAS: numerical breakdown provided (e.g., \"80% European, 15% East Asian, 5% African\" OR sample sizes per ancestry group)</li><li>For admixed populations: either ancestry proportions OR population-specific labels (e.g., \"African American,\" \"Hispanic/Latino\")</li></ul><p><strong>Score 0 if ANY of the following:</strong></p><ul><li>Ancestry described only as \"diverse,\" \"mixed,\" or \"multi-ethnic\" without specifics</li><li>Missing ancestry information for either exposure or outcome GWAS</li><li>Multi-ancestry GWAS mentioned without numerical breakdown</li></ul></td></tr><tr><td><p><strong>B2</strong></p></td><td><p><strong>Cross-Ancestry Harmonization</strong></p></td><td><p>Are exposure and outcome GWAS ancestry-matched, or is ancestry mismatch explicitly tested?</p></td><td><p><strong>Score 1 if ANY of the following:</strong></p><ul><li>Both exposure and outcome GWAS use identical ancestry populations (e.g., both European-only)</li><li>Cross-ancestry analysis with explicit testing: stratified analysis by ancestry reported</li><li>Replication performed in matched ancestry groups</li><li>Formal heterogeneity testing across ancestry groups with results discussed</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Exposure and outcome GWAS use different ancestries without any testing or justification</li><li>Authors acknowledge mismatch but provide no empirical evaluation</li></ul></td></tr><tr><td><p><strong>B3</strong></p></td><td><p><strong>LD Structure Compatibility</strong></p></td><td><p>Is ancestry-appropriate LD reference panel used for instrument selection and pruning?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>LD reference panel explicitly named (e.g., \"1000 Genomes Phase 3 EUR,\" \"gnomAD v3.1 EAS\")</li><li>Reference panel ancestry matches GWAS ancestry for instrument selection</li><li>LD pruning parameters stated (r¬≤ threshold, window size)</li><li>For multi-ancestry: either ancestry-specific panels used OR justification for single panel provided</li></ul><p><strong>Score 0 if ANY missing:</strong></p><ul><li>LD reference panel not named</li><li>Clear ancestry mismatch between panel and GWAS</li><li>LD parameters not specified</li></ul></td></tr><tr><td><p><strong>B4</strong></p></td><td><p><strong>Ancestry-Specific Instrument Strength</strong></p></td><td><p>Is instrument strength evaluated separately for each ancestry group?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>F-statistics OR R¬≤ reported separately for each ancestry in exposure GWAS</li><li>For single-ancestry exposure with multi-ancestry outcome: strength metrics calculated using ancestry-matched exposure data</li><li>Weak instrument bias discussed in context of ancestry-specific effects</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only pooled/overall instrument strength reported</li><li>Ancestry-specific strength not evaluated despite multi-ancestry data</li></ul></td></tr><tr><td><p><strong>B5</strong></p></td><td><p><strong>Allele Frequency Validation</strong></p></td><td><p>Are minor allele frequencies (MAF) reported and appropriate thresholds applied per ancestry?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>MAF thresholds explicitly stated (e.g., \"MAF &gt; 0.01,\" \"MAF &gt; 0.05\")</li><li>MAF filtering applied separately by ancestry OR ancestry-specific MAF values reported</li><li>Number of SNPs excluded due to low MAF reported by ancestry group (if applicable)</li></ul><p><strong>Score 0 if:</strong></p><ul><li>MAF thresholds not specified</li><li>Only pooled MAF filtering without ancestry consideration</li><li>MAF information completely absent</li></ul></td></tr><tr><td><p><strong>B6</strong></p></td><td><p><strong>Instrument Transferability</strong></p></td><td><p>Is the validity of applying genetic instruments across ancestries explicitly justified?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following:</strong></p><ul><li><strong>Empirical replication:</strong> MR analysis replicated in target ancestry with results compared</li><li><strong>LD/frequency comparison:</strong> Explicit comparison of instrument LD patterns or allele frequencies across ancestries with data shown</li><li><strong>Biological justification:</strong> Stated rationale for cross-ancestry generalizability referencing conserved biological pathways, gene function, or mechanistic studies</li><li><strong>Literature support: </strong>Citations to studies demonstrating cross-ancestry validity of specific instruments used</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No justification provided for cross-ancestry instrument application</li><li>Only general statements about genetic similarity without specific evidence</li><li>Transferability assumed without discussion</li></ul></td></tr><tr><td><p><strong>B7</strong></p></td><td><p><strong>Phenotype Consistency</strong></p></td><td><p>Are exposure and outcome phenotypes defined consistently across ancestry groups?</p></td><td><p><strong>Score 1 if ALL applicable elements present:</strong></p><p><strong><em>For binary traits:</em></strong></p><ul><li>Identical diagnostic criteria across ancestries (e.g., same ICD codes, clinical thresholds)</li><li>Case/control definitions explicitly stated for each ancestry</li></ul><p><strong><em>For continuous traits:</em></strong></p><ul><li>Measurement units consistent across ancestries (e.g., all BMI in kg/m¬≤)</li><li>Standardization methods described if units differ</li><li>Transformation procedures (log, inverse-normal) applied consistently</li></ul><p><strong>Score 0 if ANY of the following:</strong></p><ul><li>Different diagnostic criteria used across ancestries without harmonization</li><li>Measurement units inconsistent without conversion</li><li>Phenotype definitions not specified for one or more ancestry groups</li></ul></td></tr><tr><td><p><strong>B8</strong></p></td><td><p><strong>Ancestry-Stratified Analysis</strong></p></td><td><p>Are MR results reported by ancestry and/or tested for heterogeneity across ancestry groups?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following:</strong></p><ul><li>Stratified results: MR estimates reported separately for each ancestry with effect sizes and confidence intervals</li><li>Formal heterogeneity testing: Cochran\\'s Q, I¬≤, or similar tests performed across ancestries with p-values and interpretation</li><li>Meta-analysis approach: Random/fixed effects meta-analysis across ancestry groups with heterogeneity assessment</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only pooled results reported without ancestry breakdown</li><li>Heterogeneity mentioned but not formally tested</li><li>Results combined across ancestries without consideration of differences</li></ul></td></tr><tr><td><p><strong>B9</strong></p></td><td><p><strong>Colocalization Analysis</strong></p></td><td><p>Is colocalization or fine-mapping used to assess whether instruments tag the same causal variants across ancestries?</p></td><td><p><strong>Score 1 if ANY of the following methods applied:</strong></p><ul><li><strong>Formal colocalization:</strong> COLOC, eCAVIAR, or similar methods with posterior probabilities reported</li><li><strong>Fine-mapping comparison:</strong> SuSiE, FINEMAP, or credible sets compared across ancestries</li><li><strong>Lead SNP analysis:</strong> Assessment of whether lead SNPs are identical or in high LD (r¬≤ &gt; 0.8) across ancestries</li><li><strong>Conditional analysis:</strong> Testing whether signals remain after conditioning on lead variants</li></ul><p><strong>Score 0 if:</strong></p><ul><li>No assessment of variant-level concordance across ancestries</li><li>Only mentions colocalization without formal analysis</li></ul></td></tr><tr><td><p><strong>B10</strong></p></td><td><p><strong>Ancestry-Specific Pleiotropy</strong></p></td><td><p>Does the study evaluate whether SNP-outcome associations differ across ancestries independently of the exposure?</p></td><td><p><strong>Score 1 if AT LEAST ONE of the following:</strong></p><ul><li>Ancestry-stratified pleiotropy tests: MR-Egger intercepts, MR-PRESSO, or radial MR performed separately by ancestry with results compared</li><li>Confounder testing by ancestry: Instruments tested for association with known confounders in each ancestry group separately</li><li>Pathway analysis: Discussion of ancestry-specific biological pathways or gene expression differences that could affect pleiotropy</li><li>Negative control analysis: Testing instruments against negative control outcomes in each ancestry</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Only pooled pleiotropy testing without ancestry stratification</li><li>Pleiotropy discussed generally without ancestry-specific evaluation</li></ul></td></tr><tr><td><p><strong>B11</strong></p></td><td><p><strong>Population Stratification</strong></p><p><strong>[NEW ITEM]</strong></p></td><td><p>Are population stratification and cryptic relatedness adequately controlled within and across ancestry groups?</p></td><td><p><strong>Score 1 if ALL of the following:</strong></p><ul><li>Principal components (PCs) inclusion explicitly stated with number of PCs reported</li><li>Genomic control (Œª) values reported and appropriate (Œª &lt; 1.1 preferred, Œª &lt; 1.2 acceptable)</li><li>For multi-ancestry analysis: either ancestry-specific PC calculation OR justified approach for combined analysis</li><li>Relatedness filtering described (e.g., IBD &lt; 0.05, kinship thresholds)</li></ul><p><strong>Score 0 if ANY missing:</strong></p><ul><li>PC adjustment not mentioned</li><li>Genomic control not reported or Œª &gt; 1.2</li><li>No relatedness filtering described</li></ul></td></tr><tr><td><p><strong>B12</strong></p></td><td><p><strong>Effect Size Interpretation</strong></p><p><strong>[NEW ITEM]</strong></p></td><td><p>Are effect sizes interpreted appropriately considering ancestry-specific baseline risks and phenotype distributions?</p></td><td><p><strong>Score 1 if:</strong></p><ul><li>Authors acknowledge potential differences in baseline risk/phenotype distributions across ancestries</li><li>Effect sizes discussed in context of ancestry-specific clinical relevance</li><li>Absolute risk differences calculated or discussed where appropriate</li><li>Limitations regarding generalizability of effect sizes across populations mentioned</li></ul><p><strong>Score 0 if:</strong></p><ul><li>Effect sizes interpreted identically across ancestries without consideration of population differences</li><li>No discussion of clinical relevance by ancestry</li></ul></td></tr></tbody></table>\\n\\n#### Additional Scoring Guidelines\\n\\n**For Multi-Ancestry Studies:** All items in Part B are applicable\\n\\n**For Cross-Ancestry Studies (exposure and outcome from different ancestries):** Items B2, B6, B7, B10, B12 are particularly critical\\n\\n**For Single-Ancestry Studies with Multi-Ancestry GWAS:** Items B1, B3, B4, B5, B11 apply\\n\\n#### Quality Thresholds for Overall Assessment\\n\\n**High Quality Cross-Ancestry Methods:** ‚â•80% of applicable Part B items scored as 1\\n\\n**Moderate Quality:** 60-79% of applicable Part B items scored as 1\\n\\n**Low Quality:** <60% of applicable Part B items scored as 1',\n",
       " 'last_error': LastError(code='rate_limit_exceeded', message='You exceeded your current quota, please check your plan and billing details. For more information on this error, read the docs: https://platform.openai.com/docs/guides/error-codes/api-errors.'),\n",
       " 'max_completion_tokens': None,\n",
       " 'max_prompt_tokens': None,\n",
       " 'metadata': {},\n",
       " 'model': 'gpt-3.5-turbo',\n",
       " 'object': 'thread.run',\n",
       " 'parallel_tool_calls': True,\n",
       " 'required_action': None,\n",
       " 'response_format': 'auto',\n",
       " 'started_at': 1751503380,\n",
       " 'status': 'failed',\n",
       " 'thread_id': 'thread_dmtgnCOKBocZg4YFzK45VTBb',\n",
       " 'tool_choice': 'auto',\n",
       " 'tools': [FileSearchTool(type='file_search', file_search=FileSearch(max_num_results=None, ranking_options={'ranker': 'default_2024_08_21', 'score_threshold': 0.0}))],\n",
       " 'truncation_strategy': TruncationStrategy(type='auto', last_messages=None),\n",
       " 'usage': Usage(completion_tokens=0, prompt_tokens=0, total_tokens=0, prompt_token_details={'cached_tokens': 0}, completion_tokens_details={'reasoning_tokens': 0}),\n",
       " 'temperature': 1.0,\n",
       " 'top_p': 1.0,\n",
       " 'tool_resources': {},\n",
       " 'reasoning_effort': None}"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dict(GlobalDebug.run_status)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e5a46620",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "pytorch",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
